UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2014

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-34581

 

  

KRATON PERFORMANCE POLYMERS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

20-0411521

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

15710 John F. Kennedy Blvd.

Suite 300

Houston, TX 77032

281-504-4700

(Address of principal executive offices, including zip code)

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act. (Check one):

 

Large accelerated filer:

x

Accelerated filer:

¨

Non-accelerated filer:

¨

Smaller reporting company:

¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

Number of shares of Kraton Performance Polymers, Inc. Common Stock, $0.01 par value, outstanding as of July 25, 2014: 32,798,667.

 

 

 

 


 

Index to Quarterly Report

on Form 10-Q for

Quarter Ended June 30, 2014

 

 

PART I. FINANCIAL INFORMATION

Page

Item 1

  

Condensed Consolidated Financial Statements (Unaudited)

7

 

  

Condensed Consolidated Balance Sheets as of June 30, 2014 and December 31, 2013

7

 

  

Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2014 and 2013

8

 

  

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2014 and 2013

9

 

  

Condensed Consolidated Statements of Changes in Equity for the six months ended June 30, 2014 and 2013

10

 

  

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2014 and 2013

11

 

  

Notes to the Condensed Consolidated Financial Statements

12

Item 2

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

39

Item 3

  

Quantitative and Qualitative Disclosures About Market Risk

55

Item 4

  

Controls and Procedures

55

PART II. OTHER INFORMATION

 

Item 1

  

Legal Proceedings

56

Item 1A

  

Risk Factors

56

Item 6

  

Exhibits

57

 

  

Signatures

58

 

 

 

2


 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Some of the statements in this Quarterly Report on Form 10-Q under the headings “Condensed Consolidated Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We may also make written or oral forward-looking statements in our periodic reports on Forms 10-K, 10-Q and 8-K, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “believes,” “estimates,” “expects,” “projects,” “may,” “intends,” “plans” or “anticipates,” or by discussions of strategy, plans or intentions; anticipated benefits of or performance of our products; beliefs regarding opportunities for new, high-margin applications and other innovations; adequacy of cash flows to fund our working capital requirements; our investment in the joint venture with Formosa Petrochemical Corporation (“FPCC”); our expectations regarding indebtedness to be incurred by our joint venture with FPCC; our proposed combination with the styrenic block copolymer (“SBC”) business of LCY Chemical Corp. (“LCY”) and, expected synergies and other benefits therefrom and costs associated therewith; our ability to obtain a consent under the indenture governing our 6.75% senior notes in connection with our proposed combination with the SBC business of LCY; debt payments, interest payments, capital expenditures, benefit plan contributions, and income tax obligations; our anticipated 2014 capital expenditures, compliance with the MACT rule, health, safety and environmental and infrastructure and maintenance projects, projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform; our ability to ensure full access to our senior secured credit facilities; expectations regarding our counterparties’ ability to perform, including with respect to trade receivables; estimates regarding the tax expense of repatriating certain cash and short-term investments related to foreign operations; expectations regarding high-margin applications; our ability to realize certain deferred tax assets and our beliefs with respect to tax positions; expectations regarding our full year effective tax rate; estimates related to the useful lives of certain assets for tax purposes; expectations regarding our pension contributions for fiscal year 2014; estimates or expectations related to monomer costs, ending inventory levels and related estimated charges; the outcome and financial impact of legal proceedings; expectations regarding the spread between FIFO and ECRC in future periods; and projections regarding environmental costs and capital expenditures and related operational savings. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Further description of these risks and uncertainties and other important factors are set forth in this report, in our latest Annual Report on Form 10-K, including but not limited to “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, and in our other filings with the Securities and Exchange Commission, and include, but are not limited to, risks related to:

the likelihood of closing the combination with LCY, which is subject to a number of material regulatory conditions;

the business uncertainties and contractual restrictions that we and LCY are subject to while the proposed LCY Combination is pending, which could adversely affect each party’s business and operations;

failure to successfully combine the businesses in the expected time frame may adversely affect the future results of the combined organization, and, consequently, the value of our common stock;

failure to complete the LCY Combination, or significant delays in completing the LCY Combination, could negatively affect the trading price of our common stock and our future business and financial results;

the possibility that we may not realize the benefits we anticipate from the proposed redomestication of our company from Delaware to the United Kingdom;

our reliance on LyondellBasell Industries for the provision of significant operating and other services;

conditions in the global economy and capital markets;

the failure of our raw materials suppliers to perform their obligations under long-term supply agreements, or our inability to replace or renew these agreements when they expire;

limitations in the availability of raw materials we need to produce our products in the amounts or at the prices necessary for us to effectively and profitably operate our business;

3


 

significant fluctuations in raw material costs may result in volatility in our quarterly operating results and impact the market price of our common stock;

competition in our end use markets by other producers of styrenic block copolymers and by producers of products that can be substituted for our products;

our ability to produce and commercialize technological innovations;

our ability to protect our intellectual property, on which our business is substantially dependent;

the possibility that our products infringe upon the intellectual property rights of others;

a major failure of our information systems, which could harm our business;

seasonality in our business, particularly in our Paving and Roofing end use market;

our substantial indebtedness, which could adversely affect our financial condition and prevent us from fulfilling our obligations under the senior secured credit facilities and the senior notes;

financial and operating constraints related to our indebtedness;

the inherently hazardous nature of chemical manufacturing;

product liability claims and other lawsuits arising from environmental damage, personal injuries, other damages associated with chemical manufacturing or our products;

political, economic and local business risks in the various countries in which we operate;

health, safety and environmental laws, including laws that govern our employees’ exposure to chemicals deemed harmful to humans;

regulation of our company or our customers, which could affect the demand for our products or result in increased compliance and other costs;

customs, international trade, export control, antitrust, zoning and occupancy and labor and employment laws that could require us to modify our current business practices and incur increased costs;

fluctuations in currency exchange rates;

we may have additional tax liabilities;

our formation of a joint venture to expand HSBC capacity in Asia;

our relationship with our employees;

loss of key personnel or our inability to attract and retain new qualified personnel;

the fact that we generally do not enter into long-term contracts with our customers;

a decrease in the fair value of our pension assets could require us to materially increase future funding requirements of the pension plan;

domestic or international natural disasters or terrorist attacks may disrupt our operations;

Delaware law and some provisions of our organizational documents that make a takeover of our company more difficult;

our expectation that we will not pay dividends for the foreseeable future; and

we are a holding company with nominal net worth and will depend on dividends and distributions from our subsidiaries to pay any dividends.

4


 

There may be other factors of which we are currently unaware or that we deem immaterial that may cause our actual results to differ materially from the expectations we express in our forward-looking statements. Although we believe the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and, therefore, also the forward-looking statements based on these assumptions could themselves prove to be inaccurate.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them publicly in light of new information or future events.

Presentation of Financial Statements

The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

This Form 10-Q includes financial statements and related notes that present the condensed consolidated financial position, results of operations, comprehensive income (loss), and cash flows of Kraton and its subsidiaries. Kraton is a holding company whose only material asset is its investment in its wholly owned subsidiary, Kraton Polymers LLC. Kraton Polymers LLC and its subsidiaries own all of our consolidated operating assets.

 

 

 

5


 

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Kraton Performance Polymers, Inc.:

We have reviewed the accompanying condensed consolidated balance sheet of Kraton Performance Polymers, Inc. and subsidiaries (the Company) as of June 30, 2014, and the related condensed consolidated statements of operations and comprehensive income (loss) for the three-month and six-month periods ended June 30, 2014 and 2013, and the related condensed consolidated statements of changes in equity and cash flows for the six-month periods ended June 30, 2014 and 2013. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2013, and the related consolidated statements of operations, comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 27, 2014, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2013 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

/s/ KPMG LLP

Houston, Texas
July 31, 2014

 

 

 

6


 

PART I. FINANCIAL INFORMATION

Item 1.

Condensed Consolidated Financial Statements.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except par value)

 

 

June 30,

 

 

December 31,

 

 

2014

 

 

2013

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

65,891

 

 

$

175,872

 

Receivables, net of allowances of $413 and $315

 

151,780

 

 

 

129,356

 

Inventories of products

 

351,743

 

 

 

328,772

 

Inventories of materials and supplies

 

11,411

 

 

 

10,947

 

Deferred income taxes

 

10,392

 

 

 

7,596

 

Other current assets

 

25,435

 

 

 

20,665

 

Total current assets

 

616,652

 

 

 

673,208

 

Property, plant and equipment, less accumulated depreciation of $380,683 and $353,428

 

441,156

 

 

 

414,257

 

Intangible assets, less accumulated amortization of $84,244 and $78,784

 

53,925

 

 

 

57,488

 

Investment in unconsolidated joint venture

 

13,784

 

 

 

14,074

 

Debt issuance costs

 

8,083

 

 

 

9,213

 

Deferred income taxes

 

1,459

 

 

 

1,326

 

Other long-term assets

 

26,287

 

 

 

25,231

 

Total assets

$

1,161,346

 

 

$

1,194,797

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current portion of long-term debt

$

1,534

 

 

$

0

 

Accounts payable-trade

 

79,488

 

 

 

115,736

 

Other payables and accruals

 

46,910

 

 

 

54,539

 

Deferred income taxes

 

175

 

 

 

182

 

Due to related party

 

20,658

 

 

 

24,603

 

Total current liabilities

 

148,765

 

 

 

195,060

 

Long-term debt, net of current portion

 

351,912

 

 

 

350,989

 

Deferred income taxes

 

17,527

 

 

 

18,359

 

Other long-term liabilities

 

76,398

 

 

 

75,991

 

Total liabilities

 

594,602

 

 

 

640,399

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

Kraton stockholders' equity:

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized; 32,799 shares issued and outstanding at June 30, 2014; 32,547 shares issued and outstanding at December 31, 2013

 

328

 

 

 

325

 

Additional paid in capital

 

370,150

 

 

 

363,590

 

Retained earnings

 

174,061

 

 

 

170,827

 

Accumulated other comprehensive loss

 

(18,316

)

 

 

(21,252

)

Total Kraton stockholders' equity

 

526,223

 

 

 

513,490

 

Noncontrolling interest

 

40,521

 

 

 

40,908

 

Total equity

 

566,744

 

 

 

554,398

 

Total liabilities and equity

$

1,161,346

 

 

$

1,194,797

 

See Notes to Condensed Consolidated Financial Statements

7


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Sales revenue

$

323,767

 

 

$

334,543

 

 

$

635,423

 

 

$

674,650

 

Cost of goods sold

 

251,687

 

 

 

274,682

 

 

 

506,270

 

 

 

554,878

 

Gross profit

 

72,080

 

 

 

59,861

 

 

 

129,153

 

 

 

119,772

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

7,999

 

 

 

8,446

 

 

 

16,296

 

 

 

16,359

 

Selling, general and administrative

 

28,280

 

 

 

25,004

 

 

 

62,498

 

 

 

51,118

 

Depreciation and amortization

 

16,669

 

 

 

15,741

 

 

 

33,078

 

 

 

30,839

 

Total operating expenses

 

52,948

 

 

 

49,191

 

 

 

111,872

 

 

 

98,316

 

Earnings of unconsolidated joint venture

 

127

 

 

 

121

 

 

 

244

 

 

 

255

 

Interest expense, net

 

6,230

 

 

 

5,909

 

 

 

12,568

 

 

 

19,207

 

Income before income taxes

 

13,029

 

 

 

4,882

 

 

 

4,957

 

 

 

2,504

 

Income tax expense

 

2,161

 

 

 

905

 

 

 

2,283

 

 

 

2,351

 

Consolidated net income

 

10,868

 

 

 

3,977

 

 

 

2,674

 

 

 

153

 

Net income (loss) attributable to noncontrolling interest

 

(275

)

 

 

148

 

 

 

(560

)

 

 

72

 

Net income attributable to Kraton

$

11,143

 

 

$

3,829

 

 

$

3,234

 

 

$

81

 

Earnings per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.34

 

 

$

0.12

 

 

$

0.10

 

 

$

0.00

 

Diluted

$

0.33

 

 

$

0.12

 

 

$

0.10

 

 

$

0.00

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

32,268

 

 

 

32,073

 

 

 

32,215

 

 

 

32,068

 

Diluted

 

32,777

 

 

 

32,378

 

 

 

32,690

 

 

 

32,391

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

 

8


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands)

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Net income attributable to Kraton

$

11,143

 

 

$

3,829

 

 

$

3,234

 

 

$

81

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax of $0

 

1,137

 

 

 

(3,975

)

 

 

2,936

 

 

 

(13,246

)

Realized gain from interest rate swap, net of tax of $0

 

 

 

 

 

 

 

 

 

 

837

 

Unrealized loss from net investment hedge, net of tax of $0

 

 

 

 

 

 

 

 

 

 

(225

)

Other comprehensive income (loss), net of tax

 

1,137

 

 

 

(3,975

)

 

 

2,936

 

 

 

(12,634

)

Comprehensive income (loss) attributable to Kraton

 

12,280

 

 

 

(146

)

 

 

6,170

 

 

 

(12,553

)

Comprehensive income (loss) attributable to noncontrolling interest

 

479

 

 

 

(291

)

 

 

(387

)

 

 

(67

)

Consolidated comprehensive income (loss)

$

12,759

 

 

$

(437

)

 

$

5,783

 

 

$

(12,620

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

9


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)

(In thousands)

 

 

Common Stock

 

 

Additional Paid in Capital

 

 

Retained Earnings

 

 

Accumulated Other Comprehensive Income (Loss)

 

 

Total Kraton Stockholders' Equity

 

 

Noncontrolling Interest

 

 

Total Equity

 

Balance at December 31, 2012

$

323

 

 

$

354,957

 

 

$

171,445

 

 

$

(34,510

)

 

$

492,215

 

 

$

 

 

$

492,215

 

Net income

 

 

 

 

 

 

 

81

 

 

 

 

 

 

81

 

 

 

72

 

 

 

153

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

(12,634

)

 

 

(12,634

)

 

 

(139

)

 

 

(12,773

)

Consolidation of variable interest entity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,174

 

 

 

15,174

 

Exercise of stock options

 

2

 

 

 

308

 

 

 

 

 

 

 

 

 

310

 

 

 

 

 

 

310

 

Non-cash compensation related

   to equity awards

 

 

 

 

4,530

 

 

 

 

 

 

 

 

 

4,530

 

 

 

 

 

 

4,530

 

Balance at June 30, 2013

$

325

 

 

$

359,795

 

 

$

171,526

 

 

$

(47,144

)

 

$

484,502

 

 

$

15,107

 

 

$

499,609

 

Balance at December 31, 2013

$

325

 

 

$

363,590

 

 

$

170,827

 

 

$

(21,252

)

 

$

513,490

 

 

$

40,908

 

 

$

554,398

 

Net income (loss)

 

 

 

 

 

 

 

3,234

 

 

 

 

 

 

3,234

 

 

 

(560

)

 

 

2,674

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

2,936

 

 

 

2,936

 

 

 

173

 

 

 

3,109

 

Retired treasury stock

 

 

 

 

(667

)

 

 

 

 

 

 

 

 

(667

)

 

 

 

 

 

(667

)

Exercise of stock options

 

1

 

 

 

1,035

 

 

 

 

 

 

 

 

 

1,036

 

 

 

 

 

 

1,036

 

Non-cash compensation related to equity awards

 

2

 

 

 

6,192

 

 

 

 

 

 

 

 

 

6,194

 

 

 

 

 

 

6,194

 

Balance at June 30, 2014

$

328

 

 

$

370,150

 

 

$

174,061

 

 

$

(18,316

)

 

$

526,223

 

 

$

40,521

 

 

$

566,744

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

10


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

Six months ended June 30,

 

 

2014

 

 

2013

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Consolidated net income

$

2,674

 

 

$

153

 

Adjustments to reconcile consolidated net income to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

33,078

 

 

 

30,839

 

Amortization of debt premium

 

(80

)

 

 

(76

)

Amortization of debt issuance costs

 

1,108

 

 

 

6,304

 

Gain on property, plant and equipment

 

(16

)

 

 

(115

)

Earnings from unconsolidated joint venture, net of dividends received

 

243

 

 

 

167

 

Deferred income tax benefit

 

(3,565

)

 

 

(1,531

)

Share-based compensation

 

6,194

 

 

 

4,530

 

Increase in:

 

 

 

 

 

 

 

Accounts receivable

 

(21,728

)

 

 

(42,338

)

Inventories of products, materials and supplies

 

(22,639

)

 

 

(1,224

)

Other assets

 

(4,827

)

 

 

(1,818

)

Increase (decrease) in:

 

 

 

 

 

 

 

Accounts payable-trade

 

(34,610

)

 

 

(1,836

)

Other payables and accruals

 

(2,921

)

 

 

(8,880

)

Other long-term liabilities

 

408

 

 

 

3,188

 

Due to related party

 

(4,877

)

 

 

8,188

 

Net cash used in operating activities

 

(51,558

)

 

 

(4,449

)

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

(52,975

)

 

 

(34,742

)

Purchase of software and other intangibles

 

(1,789

)

 

 

(1,945

)

Settlement of net investment hedge

 

 

 

 

(2,225

)

Net cash used in investing activities

 

(54,764

)

 

 

(38,912

)

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

Proceeds from debt

 

24,000

 

 

 

40,000

 

Repayments of debt

 

(24,000

)

 

 

(136,875

)

Capital lease payments

 

(4,495

)

 

 

(950

)

Contribution from noncontrolling interest

 

 

 

 

15,174

 

Purchase of treasury stock

 

(667

)

 

 

 

Proceeds from the exercise of stock options

 

1,036

 

 

 

310

 

Debt issuance costs

 

 

 

 

(4,794

)

Net cash used in financing activities

 

(4,126

)

 

 

(87,135

)

Effect of exchange rate differences on cash

 

467

 

 

 

(4,001

)

Net decrease in cash and cash equivalents

 

(109,981

)

 

 

(134,497

)

Cash and cash equivalents, beginning of period

 

175,872

 

 

 

223,166

 

Cash and cash equivalents, end of period

$

65,891

 

 

$

88,669

 

Supplemental disclosures:

 

 

 

 

 

 

 

Cash paid during the period for income taxes, net of refunds received

$

8,665

 

 

$

5,463

 

Cash paid during the period for interest, net of capitalized interest

$

11,487

 

 

$

13,170

 

Capitalized interest

$

1,352

 

 

$

1,940

 

Supplemental non-cash disclosures:

 

 

 

 

 

 

 

Property, plant and equipment accruals

$

3,142

 

 

$

5,298

 

Asset acquired through capital lease

$

7,033

 

 

$

2,900

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

11


 

KRATON PERFORMANCE POLYMERS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Description of our Business. We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability. 

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than more commoditized products. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products such as disposable diapers and the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms.

We have a portfolio of innovations at various stages of development and commercialization, including

polyvinyl chloride alternatives for wire and cable and medical applications;

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

highly-modified asphalt (“HiMA”) for high-performance paving applications;

NEXAR family of membrane polymers for water filtration, heating, ventilation, air conditioning and breathable fabrics; and

synthetic cement formulations and polymers used for viscosity modification in oilfield applications.

We manufacture our polymers at five manufacturing facilities globally, including our flagship facility in Belpre, Ohio, as well as facilities in Germany, France, Brazil and Japan. The facility in Japan is operated by an unconsolidated manufacturing joint venture. The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements presented herein are for us and our consolidated subsidiaries, each of which is a wholly-owned subsidiary, except our 50% investment in our joint venture, Kraton Formosa Polymers Corporation (“KFPC”), located in Mailiao, Taiwan. KFPC is a variable interest entity for which we have determined that we are the primary beneficiary and, therefore, have consolidated into our financial statements. Our 50% investment in our joint venture located in Kashima, Japan is accounted for under the equity method of accounting. All significant intercompany transactions have been eliminated. These interim financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013 and reflect all normal recurring adjustments that are, in the opinion of management, necessary to present fairly our results of operations and financial position. Amounts reported in our Condensed Consolidated Statements of Operations are not necessarily indicative of amounts expected for the respective annual periods or any other interim period, in particular due to the effect of seasonal changes and weather conditions that typically affect our sales into our Paving and Roofing end use market.

12


 

Our significant accounting policies have been disclosed in Note 1 Description of Business, Basis of Presentation and Significant Accounting Policies in our most recent Annual Report on Form 10-K. There have been no changes to the policies disclosed therein. The accompanying unaudited condensed consolidated financial statements we present in this report have been prepared in accordance with those policies.

Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include

the useful lives of fixed assets;

allowances for doubtful accounts and sales returns;

the valuation of derivatives, deferred tax assets, property, plant and equipment, inventory, investments and share-based compensation; and

liabilities for employee benefit obligations, environmental matters, asset retirement obligations (“ARO”), income tax uncertainties and other contingencies.

Income Tax in Interim Periods. We conduct operations in separate legal entities in different jurisdictions. As a result, income tax amounts are reflected in these condensed consolidated financial statements for each of those jurisdictions. Tax laws and tax rates vary substantially in these jurisdictions and are subject to change based on the political and economic climate in those countries. We file our tax returns in accordance with our interpretations of each jurisdiction’s tax laws. We record our tax provision or benefit on an interim basis using the estimated annual effective tax rate. This rate is applied to the current period ordinary income or loss to determine the income tax provision or benefit allocated to the interim period.

Losses from jurisdictions for which no benefit can be realized and the income tax effects of unusual and infrequent items are excluded from the estimated annual effective tax rate. Valuation allowances are provided against the future tax benefits that arise from the losses in jurisdictions for which no benefit can be realized. The effects of unusual and infrequent items are recognized in the impacted interim period as discrete items.

The estimated annual effective tax rate may be significantly affected by nondeductible expenses and by our projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period during which such estimates are revised.

We have established valuation allowances against a variety of deferred tax assets, including net operating loss carryforwards, foreign tax credits and other income tax credits. Valuation allowances take into consideration our expected ability to realize these deferred tax assets and reduce the value of such assets to the amount that is deemed more likely than not to be recoverable. Our ability to realize these deferred tax assets is dependent on achieving our forecast of future taxable operating income over an extended period of time. We review our forecast in relation to actual results and expected trends on a quarterly basis. If we fail to achieve our operating income targets, we may change our assessment regarding the recoverability of our net deferred tax assets and such change could result in a valuation allowance being recorded against some or all of our net deferred tax assets. A change in our valuation allowance would impact our income tax expense/benefit and our stockholders’ equity and could have a significant impact on our results of operations or financial condition in future periods.

 

13


 

2. New Accounting Pronouncements

Adoption of Accounting Standards

We have implemented all new accounting pronouncements that are in effect and that management believes would materially affect our financial statements.

New Accounting Standard

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance.  The standard is effective for public entities for annual and interim periods beginning after December 15, 2016.  Early adoption is not permitted. Our evaluation of this standard is currently ongoing and therefore, the effects of this standard on our financial position, results of operations and cash flows are not yet known.

 

3. Share-Based Compensation

We account for share-based awards under the provisions of ASC 718, “Compensation—Stock Compensation.” Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award and we expense these costs using the straight-line method over the requisite service period. Share-based compensation expense was $2.6 million and $2.0 million for the three months ended June 30, 2014 and 2013, respectively, and $6.2 million and $4.5 million for the six months ended June 30, 2014 and 2013, respectively. We have historically recorded these costs in selling, general and administrative expenses; however, beginning in the second quarter of 2013, a portion of these costs were recorded in cost of goods sold and research and development expenses.

 

4. Detail of Certain Balance Sheet Accounts

     

 

June 30,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Inventories of products:

 

 

 

 

 

 

 

Finished products

$

271,187

 

 

$

246,758

 

Work in progress

 

6,148

 

 

 

5,384

 

Raw materials

 

74,408

 

 

 

76,630

 

Total inventories of products

$

351,743

 

 

$

328,772

 

Other payables and accruals:

 

 

 

 

 

 

 

Employee related

$

14,980

 

 

$

16,066

 

Interest payable

$

7,980

 

 

$

7,955

 

Other

 

23,950

 

 

 

30,518

 

Total other payables and accruals

$

46,910

 

 

$

54,539

 

Other long-term liabilities:

 

 

 

 

 

 

 

Pension and other postretirement benefits

$

57,549

 

 

$

57,924

 

Other

 

18,849

 

 

 

18,067

 

Total other long-term liabilities

$

76,398

 

 

$

75,991

 

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

Foreign currency translation adjustments

$

25,694

 

 

$

22,758

 

Net unrealized loss on net investment hedge

 

(1,926

)

 

 

(1,926

)

Pension liability

 

(42,084

)

 

 

(42,084

)

Total accumulated other comprehensive loss

$

(18,316

)

 

$

(21,252

)

 

 

14


 

5. Earnings Per Share (“EPS”)

Basic EPS is computed by dividing net income attributable to Kraton by the weighted-average number of shares outstanding during the period.

Diluted EPS is computed by dividing net income attributable to Kraton by the diluted weighted-average number of shares outstanding during the period and, accordingly, reflects the potential dilution that could occur if securities or other agreements to issue common stock, such as stock options, were exercised, settled or converted into common stock and were dilutive. The diluted weighted-average number of shares used in our diluted EPS calculation is determined using the treasury stock method.

Unvested awards of share-based payments with rights to receive dividends or dividend equivalents, such as our restricted stock awards are considered to be participating securities, and therefore, the two-class method is used for purposes of calculating EPS. Under the two-class method, a portion of net income is allocated to these participating securities and is excluded from the calculation of EPS allocated to common stock. Our restricted stock awards are subject to forfeiture and restrictions on transfer until vested and have identical voting, income and distribution rights to the unrestricted common shares outstanding. Our weighted average restricted stock awards outstanding were 523,153 and 454,726 for the three months ended June 30, 2014 and 2013, respectively, and 491,612 and 374,965 for the six months ended June 30, 2014 and 2013, respectively. We withheld 9,673 and 25,380 shares of restricted stock upon vesting to satisfy employee payroll tax withholding requirements for the three and six months ended June 30, 2014, respectively. We immediately retired all shares withheld and the transactions were reflected in additional paid in capital in the Condensed Consolidated Statements of Changes in Equity and as a purchase of treasury stock in the Condensed Consolidated Statements of Cash Flows.

The computation of diluted EPS includes weighted average restricted share units of 85,808 and 57,591 for the three months ended June 30, 2014 and 2013, respectively, and 76,595 and 47,810 for the six months ended June 30, 2014 and 2013, respectively, and weighted average performance share units of 157,771 and 67,585 for the three months ended June 30, 2014 and 2013, respectively, and 129,971 and 44,061 for the six months ended June 30, 2014 and 2013, respectively.

The computation of diluted EPS also includes stock options added under the treasury stock method, which amounted to 264,537 and 179,640 and 267,818 and 230,605 for the three and six months ended June 30, 2014 and 2013, respectively.

The computation of diluted earnings per share excludes the effect of the potential exercise of stock options that are anti-dilutive, amounting to 841,058 and 872,406 for the three months ended June 30, 2014 and 2013, respectively, and 841,058 and 851,752 for the six months ended June 30, 2014 and 2013, respectively.

 

                                        


15


 

The calculations of basic and diluted EPS are as follows:

 

 

Three months ended June 30, 2014

 

 

Three months ended June 30, 2013

 

 

Net Income Attributable to Kraton

 

 

Weighted Average Shares Outstanding

 

 

Earnings Per Share

 

 

Net Income Attributable to Kraton

 

 

Weighted Average Shares Outstanding

 

 

Earnings Per Share

 

 

(In thousands, except per share data)

 

 

(In thousands, except per share data)

 

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

$

11,143

 

 

 

32,791

 

 

 

 

 

 

$

3,829

 

 

 

32,528

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

(178

)

 

 

(523

)

 

 

 

 

 

 

(54

)

 

 

(455

)

 

 

 

 

Amounts available to common stockholders

 

10,965

 

 

 

32,268

 

 

$

0.34

 

 

 

3,775

 

 

 

32,073

 

 

$

0.12

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

178

 

 

 

523

 

 

 

 

 

 

 

54

 

 

 

455

 

 

 

 

 

Non-participating share units

 

 

 

 

244

 

 

 

 

 

 

 

 

 

 

125

 

 

 

 

 

Stock options added under the treasury stock method

 

 

 

 

265

 

 

 

 

 

 

 

 

 

 

180

 

 

 

 

 

Amounts reallocated to unvested restricted shares

 

(175

)

 

 

(523

)

 

 

 

 

 

 

(53

)

 

 

(455

)

 

 

 

 

Amounts available to stockholders and assumed conversions

$

10,968

 

 

 

32,777

 

 

$

0.33

 

 

$

3,776

 

 

 

32,378

 

 

$

0.12

 

 

 

 

Six months ended June 30, 2014

 

 

Six months ended June 30, 2013

 

 

 

 

Net Income Attributable to Kraton

 

 

Weighted Average Shares Outstanding

 

 

Earnings Per Share

 

 

Net Income Attributable to Kraton

 

 

Weighted Average Shares Outstanding

 

 

Earnings Per Share

 

 

(In thousands, except per share data)

 

 

(In thousands, except per share data)

 

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

$

3,234

 

 

 

32,707

 

 

 

 

 

 

$

81

 

 

 

32,443

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

(49

)

 

 

(492

)

 

 

 

 

 

 

(1

)

 

 

(375

)

 

 

 

 

Amounts available to common stockholders

 

3,185

 

 

 

32,215

 

 

$

0.10

 

 

 

80

 

 

 

32,068

 

 

$

0.00

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

49

 

 

 

492

 

 

 

 

 

 

 

1

 

 

 

375

 

 

 

 

 

Non-participating share units

 

 

 

 

207

 

 

 

 

 

 

 

 

 

 

92

 

 

 

 

 

Stock options added under the treasury stock method

 

 

 

 

268

 

 

 

 

 

 

 

 

 

 

231

 

 

 

 

 

Amounts reallocated to unvested restricted shares

 

(48

)

 

 

(492

)

 

 

 

 

 

 

(1

)

 

 

(375

)

 

 

 

 

Amounts available to stockholders and assumed conversions

$

3,186

 

 

 

32,690

 

 

$

0.10

 

 

$

80

 

 

 

32,391

 

 

$

0.00

 

 

6. Long-Term Debt

Long-term debt consists of the following:

 

June 30,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

6.75% unsecured notes

$

350,908

 

 

$

350,989

 

Capital lease obligation

 

2,538

 

 

 

 

Total debt

 

353,446

 

 

 

350,989

 

Less current portion of total debt

 

1,534

 

 

 

 

Long-term debt

$

351,912

 

 

$

350,989

 

16


 

 

 

Senior Secured Credit Facilities. In March 2013, we entered into an asset-based revolving credit facility consisting of a $150.0 million U.S. senior secured revolving credit facility (the “U.S. Facility”) and a $100.0 million Dutch senior secured revolving credit facility (the “Dutch Facility,” and together with the U.S. Facility, the “Senior Secured Credit Facilities”). Borrowing under the Senior Secured Credit Facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security.

We may request up to an aggregate of $100.0 million of additional revolving facility commitments of which up to an aggregate of $40.0 million may be additional Dutch revolving facility commitments, provided that we satisfy additional conditions described in the Senior Secured Credit Facilities, and provided further that the U.S. revolver commitment is at least 60% of the commitments after giving effect to such increase.

Kraton Polymers U.S. LLC and Kraton Polymers Nederland B.V. are the borrowers under the Senior Secured Credit Facilities, and Kraton Performance Polymers, Inc., Kraton Polymers LLC, Elastomers Holdings LLC and Kraton Polymers Capital Corporation are the guarantors for both the U.S. Facility and the Dutch Facility. In addition, K.P. Global Holdings C.V. and Kraton Polymers Holdings B.V. are guarantors for the Dutch Facility. The Senior Secured Credit Facilities terminate on March 27, 2018; however, we may from time to time request that the lenders extend the maturity of their commitments. Availability under the Senior Secured Credit Facilities is limited to the lesser of the borrowing base and total commitments (less certain reserves).

The Senior Secured Credit Facilities are principally secured by receivables and inventory. The U.S. Facility provides for borrowings in the United States and is secured by assets located in the United States. The Dutch Facility provides for borrowings outside of the United States and is secured by assets located outside of the United States.

Borrowings under the U.S. Facility (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% and (3) LIBOR plus 1.0%, or (b) a rate based on LIBOR, in each case plus an applicable margin. U.S. swingline loans shall bear interest at a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% or (3) LIBOR plus 1.0%, in each case plus an applicable margin.

Borrowings under the Dutch Facility (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded, or (b) a rate based on LIBOR, in each case plus an applicable margin. Dutch swingline loans shall bear interest at a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded.

The applicable margin is subject to a minimum of 0.5% and a maximum of 1.0% with respect to U.S. base rate loans, and a minimum of 1.5% and maximum of 2.0% for foreign base rate borrowings, and a minimum of 1.5% and maximum of 2.0% for both U.S. and foreign LIBOR loans and is subject to adjustment based on the borrowers’ excess availability of the applicable facility for the most recent fiscal quarter.

In addition to paying interest on outstanding principal amounts under the Senior Secured Credit Facilities, the borrowers will be required to pay a commitment fee in respect of the unutilized commitments at an annual rate of 0.375%.

The Senior Secured Credit Facilities contain a financial covenant that if either (a) excess availability is less than the greater of (i) 12.5% of the lesser of the commitments and the borrowing base and (ii) $31,250,000 or (b) U.S. availability is less than the greater of (i) 12.5% of the lesser of the U.S. commitments and U.S. borrowing base and (ii) $18,750,000, then following such event, Kraton and its restricted subsidiaries must maintain a fixed charge coverage ratio of at least 1.0 to 1.0 for four fiscal quarters (or for a shorter duration if certain financial conditions are met). The Senior Secured Credit Facilities contain certain customary events of default, including, without limitation, a failure to make payments under the facility, cross-default and cross-judgment default, certain bankruptcy events and certain change of control events.

17


 

As of June 30, 2014, our available borrowing capacity was $231.8 million of which $0.0 million was drawn. As of the date of this filing, our available borrowing capacity was $231.9 million, of which $0.0 million was drawn.

6.75% Senior Notes due 2019. Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019 pursuant to an indenture dated February 11, 2011 ($250.0 million senior notes) and supplemental indenture thereto dated March 20, 2012 ($100.0 million senior notes). The indenture provides that the notes are general unsecured, senior obligations and will be unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year.

Capital Lease. In January 2014, we entered into a 10 year capital lease with a principal amount of $7.0 million to fund a portion of our capital expenditures. 

Debt Maturities. The remaining principal payments on our outstanding total debt as of June 30, 2014, are as follows:

 

 

Principal Payments

 

 

(In thousands)

 

June 30:

 

 

 

2015

$

1,534

 

2016

 

90

 

2017

 

95

 

2018

 

95

 

Thereafter

 

350,724

 

Total debt

$

352,538

 

 

See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for fair value information related to our long-term debt.

 

7. Debt Issuance Costs

We capitalize the debt issuance costs related to issuing long-term debt and amortize these costs using the effective interest method, except for costs related to revolving debt, which are amortized using the straight-line method. Amortization of debt issue costs and the accelerated write-off of debt issue costs in connection with refinancing activities are recorded as a component of interest expense. We had net debt issuance costs of $10.3 million and $11.4 million (of which $2.2 million and $2.2 million were included in other current assets) as of June 30, 2014 and December 31, 2013, respectively. In connection with the March 2013 refinancing of our indebtedness, we charged to interest expense $5.0 million of unamortized debt issuance costs related to our previously existing indebtedness and we capitalized $4.8 million of debt issuance costs related to our new indebtedness. We amortized $0.6 million and $0.5 million of debt issuance costs for the three months ended June 30, 2014 and 2013, respectively, and $1.1 million and $1.3 million (which excludes the $5.0 million of accelerated amortization) of debt issuance costs for the six months ended June 30, 2014 and 2013, respectively.

 

8. Fair Value Measurements, Financial Instruments and Credit Risk

ASC 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 requires entities to, among other things, maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

18


 

ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions.

In accordance with ASC 820, these two types of inputs have created the following fair value hierarchy:

·

Level 1—Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets;

·

Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

·

Quoted prices for similar assets or liabilities in active markets

·

Quoted prices for identical or similar assets or liabilities in markets that are not active

·

Inputs other than quoted prices that are observable for the asset or liability

·

Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

·

Level 3—Inputs that are unobservable and reflect our assumptions used in pricing the asset or liability based on the best information available under the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

Recurring Fair Value Measurements. The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2014 and December 31, 2013. These financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment, which judgment may affect the valuation of their fair value and their placement within the fair value hierarchy levels.

 

 

 

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

Balance Sheet Location

 

June 30, 2014

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

 

 

(In thousands)

 

Retirement plan asset

Other long-term assets

 

$

2,010

 

 

$

2,010

 

 

$

-

 

 

$

-

 

 

 

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

Balance Sheet Location

 

December 31, 2013

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

 

 

(In thousands)

 

Retirement plan asset

Other long-term assets

 

$

1,908

 

 

$

1,908

 

 

 

 

 

 

 

 

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts, which we seek to minimize by limiting our counterparties to major financial institutions with acceptable credit ratings and by monitoring the total value of positions with individual counterparties. In the event of a default by one of our counterparties, we may not receive payments provided for under the terms of our derivatives.

19


 

The following table presents the carrying values and approximate fair values of our long-term debt.

 

 

 

June 30, 2014

 

 

December 31, 2013

 

 

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

 

 

(In thousands)

 

 

(In thousands)

 

6.75% unsecured notes (quoted prices in active market for identical assets - level 1)

 

$

350,908

 

 

$

369,688

 

 

$

350,989

 

 

$

369,250

 

Capital lease obligation (significant other observable inputs - level 2)

 

$

2,538

 

 

$

2,538

 

 

$

 

 

$

 

Financial Instruments    

Interest Rate Swap Agreements. In June 2011, we entered into a $75.0 million notional amount interest rate swap agreement with respect to a portion of our outstanding term loans to hedge against interest rate fluctuations on a portion of our variable rate debt, which was designated as a cash flow hedge. This agreement was effective on July 15, 2011 and was set to expire on June 15, 2014. However, on March 27, 2013, in connection with the refinancing of our credit facility, we terminated and settled the interest rate swap agreement, and as a result, recognized $0.7 million of interest expense for the three months ended March 31, 2013. We did not have any interest rate swap agreements in effect during the three and six months ended June 30, 2014.

Fair Value Hedges. In April 2012, we entered into a series of non-deliverable forward contracts to reduce our exposure to fluctuations in the Canadian dollar (“CAD”) against the U.S. dollar associated with the funding of certain capital expenditures. These non-deliverable forward contracts qualified for hedge accounting and were designated as fair value hedges in accordance with ASC 815-25 “Fair Value Hedges.” The non-deliverable forward contracts outstanding as of June 30, 2013 had notional amounts of CAD $2.5 million and CAD $1.6 million with settlement dates of September 9, 2013 and October 8, 2013, respectively. These hedges were effective in offsetting our exposure to the CAD and therefore the $0.1 million loss on these hedges was offset by the $0.1 million gain on the exposure associated with the funding of our semi-works facility for the three and six months ended June 30, 2013. We did not have any fair value hedges in place during the three and six months ended June 30, 2014.                              

Net Investment Hedges. During 2012, we entered into a series of non-deliverable forward and foreign currency option contracts to protect our net investment in our European subsidiaries against adverse changes in exchange rates by fixing the U.S. dollar/Euro exchange rate. The notional amounts of these contracts ranged from €50.0 million to €100.0 million with all contracts expiring after thirty days. In June 2013, we entered into a TWD 450.0 million notional amount non-deliverable forward contract to protect our net investment in our subsidiary in Taiwan against adverse changes in exchange rates by fixing the New Taiwan Dollar/Euro exchange rate. These contracts qualify for hedge accounting and were designated as net investment hedges in accordance with ASC 815-35 “Net Investment Hedges.” We recorded an aggregate $0.2 million loss in accumulated other comprehensive loss related to the settlement of the effective portion of these contracts during the six months ended June 30, 2013. We did not have any net investment hedges in place during the three and six months ended June 30, 2014.

Foreign Currency Hedges. Periodically, we enter into foreign currency agreements to hedge or otherwise protect against fluctuations in foreign currency exchange rates. The contracts are structured such that the underlying foreign currency exchange gains/losses would be offset by the mark-to-market impact of the hedging instruments and reduce the impact of foreign currency exchange movements throughout the period. These agreements typically do not qualify for hedge accounting and gains/losses resulting from both the up-front premiums and/or settlement of the hedges at expiration of the agreements are recognized in the period in which they are incurred. For the three months ended June 30, 2014 and 2013, we settled these hedges and recorded a loss of $0.2 million and a loss of $0.06 million, respectively, and for the six months ended June 30, 2014 and 2013, we recorded a loss of $0.4 million and a loss of $1.8 million, respectively, which are recorded in cost of goods sold.

Credit Risk

We analyze our counterparties’ financial condition prior to extending credit and we establish credit limits and monitor the appropriateness of those limits on an ongoing basis. We also obtain cash, letters of credit or other acceptable forms of security from customers to provide credit support, where appropriate, based on our financial analysis of the customer and the contractual terms and conditions applicable to each transaction.

20


 

 

9. Income Taxes

 

Our income tax expense was $2.2 million and $0.9 million for the three months ended June 30, 2014 and 2013, respectively, and $2.3 million and $2.4 million for the six months ended June 30, 2014 and 2013, respectively. Our effective tax rate was 16.6% and 18.5% for the three months ended June 30, 2014 and 2013, respectively, and 46.1% and 93.9% for the six months ended June 30, 2014 and 2013, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and the change in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. As of June 30, 2014 and December 31, 2013, a valuation allowance of $89.8 million and $90.0 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We decreased our valuation allowance by $0.7 million and $3.1 million for the three months ended June 30, 2014 and 2013, respectively, which represents the utilization of net operating losses. We decreased our valuation allowance by $0.2 million for the six months ended June 30, 2014, primarily due to the utilization of net operating losses. We increased our valuation allowance by $4.3 million for the six months ended June 30, 2013, of which $4.5 million represents current period net operating losses, partially offset by $0.2 million which represents changes in other comprehensive income (loss). Excluding the change in our valuation allowance, our effective tax rate would have been 21.7% and 81.1% for the three months ended June 30, 2014 and 2013, respectively, and 50.2% and an 88.1% benefit for the six months ended June 30, 2014 and 2013, respectively.

As of June 30, 2014 and December 31, 2013, we had total unrecognized tax benefits of $6.9 million and $6.4 million, respectively, related to uncertain foreign tax positions, all of which, if recognized, would impact our effective tax rate. During the three months ended June 30, 2014 and 2013, we had an increase in uncertain tax positions of $0.2 million and $0.6 million, respectively, and $0.5 million and $1.1 million during the six months ended June 30, 2014 and 2013, respectively, primarily related to uncertain tax positions in Europe. We recorded interest and penalties related to unrecognized tax benefits within the provision for income taxes. We believe that no current tax positions that have resulted in unrecognized tax benefits will significantly increase or decrease within one year.

We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. For our U.S. federal income tax returns, the statute of limitations has expired through the tax year ended December 31, 2003. As a result of net operating loss carryforwards from 2004, the statute of limitations remains open for all years subsequent to 2003. In addition, open tax years for state and foreign jurisdictions remain subject to examination.

      

    

 

10. Commitments and Contingencies

Legal Proceedings. We received notice from the tax authorities in Brazil assessing R$5.9 million, or $2.7 million (converted at the June 30, 2014 exchange rate), in connection with tax credits that were generated from the purchase of certain goods which were subsequently applied by us against taxes owed. We have appealed the assertion by the tax authorities in Brazil that the goods purchased were not eligible to earn the credits. While the outcome of this proceeding cannot be predicted with certainty, we do not expect this matter to have a material adverse effect upon our financial position, results of operations or cash flows.

We and certain of our subsidiaries, from time to time, are parties to various other legal proceedings, claims and disputes that have arisen in the ordinary course of business. These claims may involve significant amounts, some of which would not be covered by insurance. A substantial settlement payment or judgment in excess of our accruals could have a material adverse effect on our financial position, results of operations or cash flows. While the outcome of these proceedings cannot be predicted with certainty, our management does not expect any of these existing matters, individually or in the aggregate, to have a material adverse effect upon our financial position, results of operations or cash flows.

21


 

Asset Retirement Obligations.

The changes in the aggregate carrying amount of our ARO liability are as follows:

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Beginning balance

$

10,497

 

 

$

9,837

 

Accretion expense

 

271

 

 

 

251

 

Obligations settled

 

(46

)

 

 

 

Foreign currency translation, net

 

(23

)

 

 

(63

)

Ending Balance

$

10,699

 

 

$

10,025

 

 

Production downtime. In the first quarter of 2014 we experienced weather-related downtime at our Belpre, Ohio facility. In addition, our facility in Berre, France experienced an operating disruption resulting from a small fire that impacted one of the production lines at this facility. We incurred $13.0 million of costs in the six months ended June 30, 2014 associated with these two events, of which $2.4 million is included in other payables and accruals at June 30, 2014 based on management’s estimates of the remaining costs to be incurred. No costs were incurred in the three months ended June 30, 2014.

There have been no other material changes to our Commitments and Contingencies disclosed in our most recently filed Annual Report on Form 10-K.

 

11. Employee Benefits

Retirement Plans.

The components of net periodic benefit cost related to U.S. pension benefits are as follows:

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

Service cost

$

647

 

 

$

762

 

 

$

1,400

 

 

$

1,700

 

Interest cost

 

1,575

 

 

 

1,385

 

 

 

3,085

 

 

 

2,795

 

Expected return on plan assets

 

(1,920

)

 

 

(1,650

)

 

 

(3,835

)

 

 

(3,305

)

Amortization of prior service cost

 

490

 

 

 

858

 

 

 

920

 

 

 

1,865

 

Net periodic benefit cost

$

792

 

 

$

1,355

 

 

$

1,570

 

 

$

3,055

 

 

We made contributions of $3.0 million and $2.6 million to our pension plan in the six months ended June 30, 2014 and 2013, respectively.

The components of net periodic benefit cost related to other post-retirement benefits are as follows:

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

Service cost

$

110

 

 

$

145

 

 

$

235

 

 

$

290

 

Interest cost

 

285

 

 

 

293

 

 

 

605

 

 

 

585

 

Amortization of prior service cost

 

47

 

 

 

182

 

 

 

160

 

 

 

364

 

Net periodic benefit cost

$

442

 

 

$

620

 

 

$

1,000

 

 

$

1,239

 

 

22


 

 

 

12. Industry Segment and Foreign Operations

We operate in one segment for the manufacturing and marketing of engineered polymers. In accordance with the provisions of ASC 280, “Segment Reporting,” our chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Since we operate in one segment and in one group of similar products, all financial segment and product line information required by ASC 280 can be found in the condensed consolidated financial statements.

We manufacture our products along the following primary product lines based upon polymer chemistry and process technologies:

un-hydrogenated SBCs (“USBCs”);

hydrogenated SBCs (“HSBCs”);

Cariflex™ isoprene rubber and isoprene rubber latex; and

compounds.

Sales revenue for our product lines is as follows: 

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

USBCs

$

181,115

 

 

$

192,543

 

 

$

346,636

 

 

$

389,316

 

HSBCs

 

106,178

 

 

 

104,937

 

 

 

209,955

 

 

 

213,031

 

Cariflex

 

29,242

 

 

 

29,244

 

 

 

64,605

 

 

 

56,273

 

Compounds

 

7,144

 

 

 

7,544

 

 

 

14,044

 

 

 

15,448

 

Other

 

88

 

 

 

275

 

 

 

183

 

 

 

582

 

 

$

323,767

 

 

$

334,543

 

 

$

635,423

 

 

$

674,650

 

 

For geographic reporting, sales revenue is attributed to the geographic location in which the customers’ facilities are located. Long-lived assets consist primarily of property, plant and equipment, which are attributed to the geographic location in which they are located and are presented at historical cost.


23


 

Sales revenue and long-lived assets by geographic region are as follows:

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

Sales revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

$

100,956

 

 

$

100,929

 

 

$

202,618

 

 

$

214,237

 

Germany

 

39,971

 

 

 

42,304

 

 

 

80,612

 

 

 

85,685

 

China

 

20,313

 

 

 

17,503

 

 

 

39,305

 

 

 

36,193

 

Japan

 

19,801

 

 

 

20,080

 

 

 

37,482

 

 

 

37,131

 

Thailand

 

10,936

 

 

 

10,182

 

 

 

27,184

 

 

 

20,164

 

Brazil

 

12,365

 

 

 

12,984

 

 

 

26,508

 

 

 

26,881

 

Belgium

 

17,100

 

 

 

12,432

 

 

 

25,286

 

 

 

23,114

 

France

 

11,531

 

 

 

11,361

 

 

 

24,010

 

 

 

23,195

 

United Kingdom

 

10,268

 

 

 

10,285

 

 

 

18,420

 

 

 

20,759

 

Italy

 

7,345

 

 

 

10,927

 

 

 

17,566

 

 

 

23,398

 

Netherlands

 

6,259

 

 

 

6,577

 

 

 

13,286

 

 

 

16,214

 

Malaysia

 

5,585

 

 

 

7,385

 

 

 

12,067

 

 

 

13,138

 

Sweden

 

6,496

 

 

 

5,499

 

 

 

10,921

 

 

 

9,572

 

Taiwan

 

6,102

 

 

 

3,493

 

 

 

10,669

 

 

 

9,939

 

Canada

 

4,631

 

 

 

4,919

 

 

 

8,664

 

 

 

9,679

 

Argentina

 

4,406

 

 

 

4,246

 

 

 

8,596

 

 

 

8,911

 

Mexico

 

4,463

 

 

 

4,809

 

 

 

8,210

 

 

 

9,683

 

South Korea

 

4,954

 

 

 

3,936

 

 

 

7,895

 

 

 

7,159

 

Turkey

 

3,245

 

 

 

5,914

 

 

 

6,552

 

 

 

11,590

 

Austria

 

3,635

 

 

 

4,344

 

 

 

6,450

 

 

 

6,070

 

Poland

 

2,905

 

 

 

2,385

 

 

 

4,596

 

 

 

3,811

 

All other countries

 

20,500

 

 

 

32,049

 

 

 

38,526

 

 

 

58,127

 

 

$

323,767

 

 

$

334,543

 

 

$

635,423

 

 

$

674,650

 

 

     

June 30,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Long-lived assets, at cost:

 

 

 

 

 

 

 

United States

$

476,610

 

 

$

453,157

 

France

 

124,000

 

 

 

123,804

 

Brazil

 

81,960

 

 

 

76,524

 

Germany

 

65,069

 

 

 

64,258

 

Netherlands

 

29,697

 

 

 

27,865

 

Taiwan

 

35,317

 

 

 

12,935

 

China

 

7,196

 

 

 

7,226

 

Japan

 

1,770

 

 

 

1,696

 

All other countries

 

220

 

 

 

220

 

 

$

821,839

 

 

$

767,685

 

 

 

24


 

13. Related Party Transactions

We own a 50% equity investment in a SBC manufacturing joint venture in Kashima, Japan. Our due to related party liability on the condensed consolidated balance sheet is related to this joint venture and the purchases from the joint venture amounted to $6.8 million and $10.1 million for the three months ended June 30, 2014 and 2013, respectively, and $20.6 million and $22.7 million for the six months ended June 30, 2014 and 2013, respectively.

    

14. Variable Interest Entity

 

The following table summarizes the carrying amounts of assets and liabilities as of June 30, 2014 and December 31, 2013 for Kraton Formosa Polymers Corporation (“KFPC”), our 50/50 joint venture with Formosa Petrochemical Corporation, before intercompany eliminations. See Note 16 Subsequent Events, for further discussion related to KFPC.

 

 

June 30,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Cash and cash equivalents

 

36,498

 

 

 

66,816

 

Other current assets

 

1,253

 

 

 

256

 

Property, plant and equipment

 

35,264

 

 

 

12,912

 

Intangible assets

 

10,136

 

 

 

10,094

 

Other long-term assets

 

448

 

 

 

462

 

Total assets

$

83,599

 

 

$

90,540

 

Current liabilities

 

2,557

 

 

 

8,724

 

Total liabilities

$

2,557

 

 

$

8,724

 

 

15. Proposed Business Combination

On January 28, 2014, we executed a definitive agreement to combine with the styrenic block copolymer (“SBC”) operations of Taiwan-based LCY Chemical Corp. (“LCY”). The combination agreement calls for LCY to contribute its SBC business in exchange for newly issued shares in the combined company, such that Kraton’s stockholders and LCY would each own 50% of the outstanding shares of the combined enterprise.  

On June 24, 2014, we provided an update of the first quarter 2014 results for LCY’s SBC business, which were lower than forecasted, and we provided revised financial projections for LCY’s SBC business. As a result of these financial results, the related decline in Kraton’s stock price and negative reactions from our stockholders, on June 30, 2014, we notified LCY that our Board of Directors intends to withdraw its recommendation that Kraton stockholders approve the previously announced combination agreement. Before the Kraton Board changes its recommendation Kraton was required by the combination agreement to provide LCY with at least five business days' written notice of the intention to withdraw or change its recommendation.

 

Our announcement of the notice to LCY stated that LCY and Kraton may engage in negotiations to determine whether they can mutually agree to changes in the terms of the combination agreement as would enable the Kraton Board to continue to recommend the transaction to Kraton stockholders. Kraton cannot predict whether any such negotiations will result in mutually agreeable changes to the combination agreement. Kraton does not intend to make further public comment regarding the status of any such negotiations unless and until the parties enter into an amendment to the combination agreement effecting such changes, or unless and until Kraton determines that any such negotiations have been abandoned. In either such event, such process may take longer than the minimum five business days provided in the combination agreement. The combination agreement will remain in effect unless and until it is terminated in accordance with its terms.

25


 

 

16. Subsequent Events

On July 17, 2014, KFPC executed a syndicated loan agreement (the “KFPC Loan Agreement”) in the amount of 5.5 billion New Taiwan Dollars (“NTD”), or $182.9 million (converted at the July 17, 2014 exchange rate), to provide additional funding to construct the HSBC facility in Taiwan, and to provide funding for working capital requirements and/or general corporate purposes.

The KFPC Loan Agreement is comprised of NTD 4.29 billion, or $142.7 million (converted at the July 17, 2014 exchange rate), to fund KFPC’s capital expenditures and NTD 1.21 billion, or $40.2 million (converted at the July 17, 2014 exchange rate), to fund working capital requirements and/or general corporate purposes. The initial term of the KFPC Loan Agreement is five years from the date of the first drawing of loans. To the extent that the first drawing has not occurred within six months from the date of the KFPC Loan Agreement, the term will be five years from expiration of this six-month period. Subject to certain conditions, KFPC can request a two-year extension of the term of the KFPC Loan Agreement.

The total outstanding principal amount is payable  in six semi-annual installments with the first payment due upon the expiry of a thirty-month period commencing on the first drawdown date and each subsequent payment due every six months thereafter. The first five installments shall be in an amount equal to 10% of the outstanding principal amount and the final installment shall be in an amount equal to the remaining 50% of the outstanding principal amount. In the event the extension period is granted, the final 50% of the outstanding principal amount shall be repaid in five equal semi-annual installments.

The KFPC Loan Agreement is subject to a variable interest rate composed of a fixed 0.8% margin plus the secondary market fixing rate in Taiwan Dollar denominated 90 day or 180 day commercial paper, (depending on the interest period as selected by KFPC in the drawdown request or the interest period notice), subject to a floor of 1.7%. Interest is payable on a monthly basis.

The KFPC Loan Agreement contains certain financial covenants, including a debt to equity ratio, an interest coverage ratio and a minimum tangible net worth requirement, calculated and tested on an annual basis. Formosa Petrochemical Corporation and Kraton Polymers LLC are the guarantors of the KFPC Loan Agreement with each guarantor guaranteeing fifty percent (50%) of the indebtedness.

We have evaluated significant events and transactions that occurred after the balance sheet date and determined that there were no events or transactions other than the execution of the KFPC Loan Agreement by KFPC disclosed above that would require recognition or disclosure in our condensed consolidated financial statements for the period ended June 30, 2014.

17. Supplemental Guarantor Information

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, (“the Issuers”), are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Performance Polymers, Inc. and Elastomers Holdings LLC, a U.S. holding company and wholly-owned subsidiary of Kraton Polymers LLC, collectively, (“the Guarantors”), fully and unconditionally guarantee on a joint and several basis, the Issuers’ obligations under the 6.75% senior notes. Our remaining subsidiaries are not guarantors of the 6.75% senior notes. We do not believe that separate financial statements and other disclosures concerning the guarantor subsidiaries would provide any additional information that would be material to investors in making an investment decision.

 

 


26


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

June 30, 2014

(Unaudited)

(In thousands, except par value)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

 

 

$

116

 

 

$

2,621

 

 

$

63,154

 

 

$

 

 

$

65,891

 

Receivables, net of allowances

 

 

 

 

272

 

 

 

55,412

 

 

 

96,096

 

 

 

 

 

 

151,780

 

Inventories of products

 

 

 

 

(632

)

 

 

198,806

 

 

 

153,569

 

 

 

 

 

 

351,743

 

Inventories of materials and supplies

 

 

 

 

 

 

 

9,281

 

 

 

2,130

 

 

 

 

 

 

11,411

 

Deferred income taxes

 

 

 

 

 

 

 

3,953

 

 

 

6,439

 

 

 

 

 

 

10,392

 

Other current assets

 

 

 

 

6,048

 

 

 

607

 

 

 

18,780

 

 

 

 

 

 

25,435

 

Total current assets

 

 

 

 

5,804

 

 

 

270,680

 

 

 

340,168

 

 

 

 

 

 

616,652

 

Property, plant and equipment, less accumulated depreciation

 

 

 

 

50,754

 

 

 

242,622

 

 

 

147,780

 

 

 

 

 

 

441,156

 

Intangible assets, less accumulated amortization

 

 

 

 

49,487

 

 

 

4,853

 

 

 

(415

)

 

 

 

 

 

53,925

 

Investment in consolidated subsidiaries

 

544,539

 

 

 

1,365,686

 

 

 

 

 

 

 

 

 

(1,910,225

)

 

 

 

Investment in unconsolidated joint venture

 

 

 

 

813

 

 

 

 

 

 

12,971

 

 

 

 

 

 

13,784

 

Debt issuance costs

 

 

 

 

5,371

 

 

 

1,586

 

 

 

1,126

 

 

 

 

 

 

8,083

 

Deferred income taxes

 

 

 

 

482

 

 

 

 

 

 

977

 

 

 

 

 

 

1,459

 

Other long-term assets

 

 

 

 

(511

)

 

 

557,878

 

 

 

99,533

 

 

 

(630,613

)

 

 

26,287

 

Total assets

$

544,539

 

 

$

1,477,886

 

 

$

1,077,619

 

 

$

602,140

 

 

$

(2,540,838

)

 

$

1,161,346

 

LIABILITIES AND STOCKHOLDERS' AND

   MEMBER'S EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current portion of long-term debt

$

 

 

$

 

 

$

1,534

 

 

$

 

 

$

 

 

$

1,534

 

Accounts payable-trade

 

 

 

 

1,674

 

 

 

33,830

 

 

 

43,984

 

 

 

 

 

 

79,488

 

Other payables and accruals

 

 

 

 

23,375

 

 

 

11,611

 

 

 

11,924

 

 

 

 

 

 

46,910

 

Deferred income taxes

 

 

 

 

 

 

 

 

 

 

175

 

 

 

 

 

 

175

 

Due to related party

 

 

 

 

 

 

 

 

 

 

20,658

 

 

 

 

 

 

20,658

 

Total current liabilities

 

 

 

 

25,049

 

 

 

46,975

 

 

 

76,741

 

 

 

 

 

 

148,765

 

Long-term debt, net of current portion

 

 

 

 

350,908

 

 

 

1,004

 

 

 

 

 

 

 

 

 

351,912

 

Deferred income taxes

 

 

 

 

9,498

 

 

 

3,953

 

 

 

4,076

 

 

 

 

 

 

17,527

 

Other long-term liabilities

 

 

 

 

548,695

 

 

 

63,984

 

 

 

94,332

 

 

 

(630,613

)

 

 

76,398

 

Total liabilities

 

 

 

 

934,150

 

 

 

115,916

 

 

 

175,149

 

 

 

(630,613

)

 

 

594,602

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' and member's equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized

 

328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

328

 

Additional paid in capital

 

370,150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

370,150

 

Member's equity

 

 

 

 

544,539

 

 

 

997,678

 

 

 

368,008

 

 

 

(1,910,225

)

 

 

 

Retained earnings

 

174,061

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

174,061

 

Accumulated other comprehensive income (loss)

 

 

 

 

(803

)

 

 

(35,975

)

 

 

18,462

 

 

 

 

 

 

(18,316

)

Kraton stockholders' and member's equity

 

544,539

 

 

 

543,736

 

 

 

961,703

 

 

 

386,470

 

 

 

(1,910,225

)

 

 

526,223

 

Noncontrolling interest

 

 

 

 

 

 

 

 

 

 

40,521

 

 

 

 

 

 

40,521

 

Total stockholders' and member's equity

 

544,539

 

 

 

543,736

 

 

 

961,703

 

 

 

426,991

 

 

 

(1,910,225

)

 

 

566,744

 

Total liabilities and stockholders' and member's equity

$

544,539

 

 

$

1,477,886

 

 

$

1,077,619

 

 

$

602,140

 

 

$

(2,540,838

)

 

$

1,161,346

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 


27


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2013

(In thousands, except par value)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

 

 

$

 

 

$

11,792

 

 

$

164,080

 

 

$

 

 

$

175,872

 

Receivables, net of allowances

 

 

 

 

80

 

 

 

45,971

 

 

 

83,305

 

 

 

 

 

 

129,356

 

Inventories of products

 

 

 

 

 

 

 

176,823

 

 

 

151,949

 

 

 

 

 

 

328,772

 

Inventories of materials and supplies

 

 

 

 

 

 

 

8,898

 

 

 

2,049

 

 

 

 

 

 

10,947

 

Deferred income taxes

 

 

 

 

 

 

 

3,952

 

 

 

3,644

 

 

 

 

 

 

7,596

 

Other current assets

 

 

 

 

2,071

 

 

 

1,541

 

 

 

17,053

 

 

 

 

 

 

20,665

 

Total current assets

 

 

 

 

2,151

 

 

 

248,977

 

 

 

422,080

 

 

 

 

 

 

673,208

 

Property, plant and equipment, less accumulated depreciation

 

 

 

 

47,157

 

 

 

241,650

 

 

 

125,450

 

 

 

 

 

 

414,257

 

Intangible assets, less accumulated amortization

 

 

 

 

34,208

 

 

 

23,280

 

 

 

 

 

 

 

 

 

57,488

 

Investment in consolidated subsidiaries

 

534,742

 

 

 

1,325,811

 

 

 

 

 

 

 

 

 

(1,860,553

)

 

 

 

Investment in unconsolidated joint venture

 

 

 

 

813

 

 

 

 

 

 

13,261

 

 

 

 

 

 

14,074

 

Debt issuance costs

 

 

 

 

6,000

 

 

 

1,874

 

 

 

1,339

 

 

 

 

 

 

9,213

 

Deferred income taxes

 

 

 

 

536

 

 

 

 

 

 

790

 

 

 

 

 

 

1,326

 

Other long-term assets

 

 

 

 

612

 

 

 

563,305

 

 

 

108,393

 

 

 

(647,079

)

 

 

25,231

 

Total assets

$

534,742

 

 

$

1,417,288

 

 

$

1,079,086

 

 

$

671,313

 

 

$

(2,507,632

)

 

$

1,194,797

 

LIABILITIES AND STOCKHOLDERS' AND

   MEMBER'S EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable-trade

$

 

 

$

104

 

 

$

48,259

 

 

$

67,373

 

 

$

 

 

$

115,736

 

Other payables and accruals

 

 

 

 

7,875

 

 

 

25,970

 

 

 

20,694

 

 

 

 

 

 

54,539

 

Deferred income taxes

 

 

 

 

 

 

 

 

 

 

182

 

 

 

 

 

 

182

 

Due to related party

 

 

 

 

 

 

 

 

 

 

24,603

 

 

 

 

 

 

24,603

 

Total current liabilities

 

 

 

 

7,979

 

 

 

74,229

 

 

 

112,852

 

 

 

 

 

 

195,060

 

Long-term debt, net of current portion

 

 

 

 

350,989

 

 

 

 

 

 

 

 

 

 

 

 

350,989

 

Deferred income taxes

 

 

 

 

10,553

 

 

 

3,953

 

 

 

3,853

 

 

 

 

 

 

18,359

 

Other long-term liabilities

 

 

 

 

513,560

 

 

 

64,394

 

 

 

145,116

 

 

 

(647,079

)

 

 

75,991

 

Total liabilities

 

 

 

 

883,081

 

 

 

142,576

 

 

 

261,821

 

 

 

(647,079

)

 

 

640,399

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' and member's equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized

 

325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

325

 

Additional paid in capital

 

363,590

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

363,590

 

Member's equity

 

 

 

 

534,742

 

 

 

972,485

 

 

 

353,326

 

 

 

(1,860,553

)

 

 

 

Retained earnings

 

170,827

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

170,827

 

Accumulated other comprehensive income (loss)

 

 

 

 

(535

)

 

 

(35,975

)

 

 

15,258

 

 

 

 

 

 

(21,252

)

Kraton stockholders' and member's equity

 

534,742

 

 

 

534,207

 

 

 

936,510

 

 

 

368,584

 

 

 

(1,860,553

)

 

 

513,490

 

Noncontrolling interest

 

 

 

 

 

 

 

 

 

 

40,908

 

 

 

 

 

 

40,908

 

Total stockholders' and member's equity

 

534,742

 

 

 

534,207

 

 

 

936,510

 

 

 

409,492

 

 

 

(1,860,553

)

 

 

554,398

 

Total liabilities and stockholders' and member's equity

$

534,742

 

 

$

1,417,288

 

 

$

1,079,086

 

 

$

671,313

 

 

$

(2,507,632

)

 

$

1,194,797

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 


28


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended June 30, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

174,233

 

 

$

199,590

 

 

$

(50,056

)

 

$

323,767

 

Cost of goods sold

 

 

 

 

(300

)

 

 

137,364

 

 

 

164,679

 

 

 

(50,056

)

 

 

251,687

 

Gross profit

 

 

 

 

300

 

 

 

36,869

 

 

 

34,911

 

 

 

 

 

 

72,080

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

4,050

 

 

 

483

 

 

 

3,466

 

 

 

 

 

 

7,999

 

Selling, general and administrative

 

 

 

 

19,771

 

 

 

37

 

 

 

8,472

 

 

 

 

 

 

28,280

 

Depreciation and amortization

 

 

 

 

5,587

 

 

 

7,351

 

 

 

3,731

 

 

 

 

 

 

16,669

 

Total operating expenses

 

 

 

 

29,408

 

 

 

7,871

 

 

 

15,669

 

 

 

 

 

 

52,948

 

Earnings in consolidated subsidiaries

 

10,868

 

 

 

45,693

 

 

 

 

 

 

 

 

 

(56,561

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

127

 

 

 

 

 

 

127

 

Interest expense (income), net

 

 

 

 

6,223

 

 

 

39

 

 

 

(32

)

 

 

 

 

 

6,230

 

Income before income taxes

 

10,868

 

 

 

10,362

 

 

 

28,959

 

 

 

19,401

 

 

 

(56,561

)

 

 

13,029

 

Income tax expense (benefit)

 

 

 

 

(506

)

 

 

2

 

 

 

2,665

 

 

 

 

 

 

2,161

 

Consolidated net income

 

10,868

 

 

 

10,868

 

 

 

28,957

 

 

 

16,736

 

 

 

(56,561

)

 

 

10,868

 

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(275

)

 

 

 

 

 

(275

)

Net income attributable to Kraton

$

10,868

 

 

$

10,868

 

 

$

28,957

 

 

$

17,011

 

 

$

(56,561

)

 

$

11,143

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 


29


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended June 30, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

164,643

 

 

$

209,894

 

 

$

(39,994

)

 

$

334,543

 

Cost of goods sold

 

 

 

 

231

 

 

 

124,242

 

 

 

190,203

 

 

 

(39,994

)

 

 

274,682

 

Gross profit (loss)

 

 

 

 

(231

)

 

 

40,401

 

 

 

19,691

 

 

 

 

 

 

59,861

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

4,437

 

 

 

4,009

 

 

 

 

 

 

8,446

 

Selling, general and administrative

 

 

 

 

146

 

 

 

16,601

 

 

 

8,257

 

 

 

 

 

 

25,004

 

Depreciation and amortization

 

 

 

 

4,080

 

 

 

8,085

 

 

 

3,576

 

 

 

 

 

 

15,741

 

Total operating expenses

 

 

 

 

4,226

 

 

 

29,123

 

 

 

15,842

 

 

 

 

 

 

49,191

 

Earnings in consolidated subsidiaries

 

3,977

 

 

 

16,758

 

 

 

 

 

 

 

 

 

(20,735

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

121

 

 

 

 

 

 

121

 

Interest expense (income), net

 

 

 

 

9,044

 

 

 

(3,544

)

 

 

409

 

 

 

 

 

 

5,909

 

Income before income taxes

 

3,977

 

 

 

3,257

 

 

 

14,822

 

 

 

3,561

 

 

 

(20,735

)

 

 

4,882

 

Income tax expense (benefit)

 

 

 

 

(720

)

 

 

10

 

 

 

1,615

 

 

 

 

 

 

905

 

Consolidated net income

 

3,977

 

 

 

3,977

 

 

 

14,812

 

 

 

1,946

 

 

 

(20,735

)

 

 

3,977

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

148

 

 

 

 

 

 

148

 

Net income attributable to Kraton

$

3,977

 

 

$

3,977

 

 

$

14,812

 

 

$

1,798

 

 

$

(20,735

)

 

$

3,829

 

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 


30


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Six months ended June 30, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

331,071

 

 

$

390,782

 

 

$

(86,430

)

 

$

635,423

 

Cost of goods sold

 

 

 

 

(15,414

)

 

 

264,565

 

 

 

343,549

 

 

 

(86,430

)

 

 

506,270

 

Gross profit

 

 

 

 

15,414

 

 

 

66,506

 

 

 

47,233

 

 

 

 

 

 

129,153

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

8,549

 

 

 

937

 

 

 

6,810

 

 

 

 

 

 

16,296

 

Selling, general and administrative

 

 

 

 

46,467

 

 

 

125

 

 

 

15,906

 

 

 

 

 

 

62,498

 

Depreciation and amortization

 

 

 

 

11,124

 

 

 

14,522

 

 

 

7,432

 

 

 

 

 

 

33,078

 

Total operating expenses

 

 

 

 

66,140

 

 

 

15,584

 

 

 

30,148

 

 

 

 

 

 

111,872

 

Earnings in consolidated subsidiaries

 

2,674

 

 

 

64,878

 

 

 

 

 

 

 

 

 

(67,552

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

244

 

 

 

 

 

 

244

 

Interest expense (income), net

 

 

 

 

12,478

 

 

 

164

 

 

 

(74

)

 

 

 

 

 

12,568

 

Income before income taxes

 

2,674

 

 

 

1,674

 

 

 

50,758

 

 

 

17,403

 

 

 

(67,552

)

 

 

4,957

 

Income tax expense (benefit)

 

 

 

 

(1,000

)

 

 

5

 

 

 

3,278

 

 

 

 

 

 

2,283

 

Consolidated net income

 

2,674

 

 

 

2,674

 

 

 

50,753

 

 

 

14,125

 

 

 

(67,552

)

 

 

2,674

 

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(560

)

 

 

 

 

 

(560

)

Net income attributable to Kraton

$

2,674

 

 

$

2,674

 

 

$

50,753

 

 

$

14,685

 

 

$

(67,552

)

 

$

3,234

 

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.


31


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Six months ended June 30, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

342,225

 

 

$

413,445

 

 

$

(81,020

)

 

$

674,650

 

Cost of goods sold

 

 

 

 

1,964

 

 

 

272,361

 

 

 

361,573

 

 

 

(81,020

)

 

 

554,878

 

Gross profit (loss)

 

 

 

 

(1,964

)

 

 

69,864

 

 

 

51,872

 

 

 

 

 

 

119,772

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

8,780

 

 

 

7,579

 

 

 

 

 

 

16,359

 

Selling, general and administrative

 

 

 

 

148

 

 

 

35,572

 

 

 

15,398

 

 

 

 

 

 

51,118

 

Depreciation and amortization

 

 

 

 

8,159

 

 

 

15,619

 

 

 

7,061

 

 

 

 

 

 

30,839

 

Total operating expenses

 

 

 

 

8,307

 

 

 

59,971

 

 

 

30,038

 

 

 

 

 

 

98,316

 

Earnings in consolidated subsidiaries

 

153

 

 

 

34,544

 

 

 

 

 

 

 

 

 

(34,697

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

255

 

 

 

 

 

 

255

 

Interest expense (income), net

 

 

 

 

24,934

 

 

 

(7,120

)

 

 

1,393

 

 

 

 

 

 

19,207

 

Income (loss) before income taxes

 

153

 

 

 

(661

)

 

 

17,013

 

 

 

20,696

 

 

 

(34,697

)

 

 

2,504

 

Income tax expense (benefit)

 

 

 

 

(814

)

 

 

21

 

 

 

3,144

 

 

 

 

 

 

2,351

 

Consolidated net income

 

153

 

 

 

153

 

 

 

16,992

 

 

 

17,552

 

 

 

(34,697

)

 

 

153

 

Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

72

 

 

 

 

 

 

72

 

Net income attributable to Kraton

$

153

 

 

$

153

 

 

$

16,992

 

 

$

17,480

 

 

$

(34,697

)

 

$

81

 

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.


32


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

Three months ended June 30, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income attributable to Kraton

$

10,868

 

 

$

10,868

 

 

$

28,957

 

 

$

17,011

 

 

$

(56,561

)

 

$

11,143

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax

 

 

 

 

6

 

 

 

 

 

 

1,131

 

 

 

 

 

 

1,137

 

Other comprehensive income, net of tax

 

 

 

 

6

 

 

 

 

 

 

1,131

 

 

 

 

 

 

1,137

 

Comprehensive income attributable to Kraton

 

10,868

 

 

 

10,874

 

 

 

28,957

 

 

 

18,142

 

 

 

(56,561

)

 

 

12,280

 

Comprehensive income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

479

 

 

 

 

 

 

479

 

Consolidated comprehensive income

$

10,868

 

 

$

10,874

 

 

$

28,957

 

 

$

18,621

 

 

$

(56,561

)

 

$

12,759

 

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 


33


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three months ended June 30, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income attributable to Kraton

$

3,977

 

 

$

3,977

 

 

$

14,812

 

 

$

1,798

 

 

$

(20,735

)

 

$

3,829

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax

 

 

 

 

104

 

 

 

 

 

 

(4,079

)

 

 

 

 

 

(3,975

)

Other comprehensive income (loss), net of tax

 

 

 

 

104

 

 

 

 

 

 

(4,079

)

 

 

 

 

 

(3,975

)

Comprehensive income (loss) attributable to Kraton

 

3,977

 

 

 

4,081

 

 

 

14,812

 

 

 

(2,281

)

 

 

(20,735

)

 

 

(146

)

Comprehensive loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(291

)

 

 

 

 

 

(291

)

Consolidated comprehensive income (loss)

$

3,977

 

 

$

4,081

 

 

$

14,812

 

 

$

(2,572

)

 

$

(20,735

)

 

$

(437

)

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

 


34


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Six months ended June 30, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income attributable to Kraton

$

2,674

 

 

$

2,674

 

 

$

50,753

 

 

$

14,685

 

 

$

(67,552

)

 

$

3,234

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax

 

 

 

 

(268

)

 

 

 

 

 

3,204

 

 

 

 

 

 

2,936

 

Other comprehensive income (loss), net of tax

 

 

 

 

(268

)

 

 

 

 

 

3,204

 

 

 

 

 

 

2,936

 

Comprehensive income attributable to Kraton

 

2,674

 

 

 

2,406

 

 

 

50,753

 

 

 

17,889

 

 

 

(67,552

)

 

 

6,170

 

Comprehensive loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(387

)

 

 

 

 

 

(387

)

Consolidated comprehensive income

$

2,674

 

 

$

2,406

 

 

$

50,753

 

 

$

17,502

 

 

$

(67,552

)

 

$

5,783

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.


35


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Six months ended June 30, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income attributable to Kraton

$

153

 

 

$

153

 

 

$

16,992

 

 

$

17,480

 

 

$

(34,697

)

 

$

81

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax

 

 

 

 

(2

)

 

 

 

 

 

(13,244

)

 

 

 

 

 

(13,246

)

Realized gain from interest rate swap, net of tax

 

 

 

 

837

 

 

 

 

 

 

 

 

 

 

 

 

837

 

Unrealized loss from net investment hedge, net of tax

 

 

 

 

(225

)

 

 

 

 

 

 

 

 

 

 

 

(225

)

Other comprehensive income (loss), net of tax

 

 

 

 

610

 

 

 

 

 

 

(13,244

)

 

 

 

 

 

(12,634

)

Comprehensive income attributable to Kraton

 

153

 

 

 

763

 

 

 

16,992

 

 

 

4,236

 

 

 

(34,697

)

 

 

(12,553

)

Comprehensive loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(67

)

 

 

 

 

 

(67

)

Consolidated comprehensive income

$

153

 

 

$

763

 

 

$

16,992

 

 

$

4,169

 

 

$

(34,697

)

 

$

(12,620

)

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.


36


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Six months ended June 30, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Cash flows provided by (used in) operating activities

$

 

 

$

(15,142

)

 

$

35,993

 

 

$

(72,409

)

 

$

 

 

$

(51,558

)

Cash flows provided by (used in) investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from intercompany loans

 

 

 

 

15,800

 

 

 

 

 

 

 

 

 

(15,800

)

 

 

 

Purchase of property, plant and equipment

 

 

 

 

(384

)

 

 

(23,607

)

 

 

(28,984

)

 

 

 

 

 

(52,975

)

Purchase of software and other intangibles

 

 

 

 

(1,194

)

 

 

(595

)

 

 

 

 

 

 

 

 

(1,789

)

Net cash provided by (used in) investing activities

 

 

 

 

14,222

 

 

 

(24,202

)

 

 

(28,984

)

 

 

(15,800

)

 

 

(54,764

)

Cash flows provided by (used in) financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from debt

 

 

 

 

 

 

 

24,000

 

 

 

 

 

 

 

 

 

24,000

 

Repayments of debt

 

 

 

 

 

 

 

(24,000

)

 

 

 

 

 

 

 

 

(24,000

)

Capital lease payments

 

 

 

 

 

 

 

(4,495

)

 

 

 

 

 

 

 

 

(4,495

)

Purchase of treasury stock

 

(667

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(667

)

Cash contributions from member

 

 

 

 

 

 

 

(667

)

 

 

 

 

 

667

 

 

 

 

Cash distributions to member

 

(369

)

 

 

1,036

 

 

 

 

 

 

 

 

 

(667

)

 

 

 

Proceeds from the exercise of stock options

 

1,036

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,036

 

Payments on intercompany loans

 

 

 

 

 

 

 

(15,800

)

 

 

 

 

 

15,800

 

 

 

 

Net cash provided by (used in) financing activities

 

 

 

 

1,036

 

 

 

(20,962

)

 

 

 

 

 

15,800

 

 

 

(4,126

)

Effect of exchange rate differences on cash

 

 

 

 

 

 

 

 

 

 

467

 

 

 

 

 

 

467

 

Net increase (decrease) in cash and cash equivalents

 

 

 

 

116

 

 

 

(9,171

)

 

 

(100,926

)

 

 

 

 

 

(109,981

)

Cash and cash equivalents, beginning of period

 

 

 

 

 

 

 

11,792

 

 

 

164,080

 

 

 

 

 

 

175,872

 

Cash and cash equivalents, end of period

$

 

 

$

116

 

 

$

2,621

 

 

$

63,154

 

 

$

 

 

$

65,891

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.


37


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Six months ended June 30, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Cash flows provided by (used in) operating activities

$

 

 

$

2,851

 

 

$

(63,585

)

 

$

56,285

 

 

$

 

 

$

(4,449

)

Cash flows provided by (used in) investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayments of intercompany loans

 

 

 

 

80,705

 

 

 

 

 

 

 

 

 

(80,705

)

 

 

 

Purchase of property, plant and equipment

 

 

 

 

 

 

 

(9,412

)

 

 

(25,330

)

 

 

 

 

 

(34,742

)

Purchase of software and other intangibles

 

 

 

 

 

 

 

(1,770

)

 

 

(175

)

 

 

 

 

 

(1,945

)

Settlement of net investment hedge

 

 

 

 

(2,225

)

 

 

 

 

 

 

 

 

 

 

 

(2,225

)

Net cash provided by (used in) investing activities

 

 

 

 

78,480

 

 

 

(11,182

)

 

 

(25,505

)

 

 

(80,705

)

 

 

(38,912

)

Cash flows provided by (used in) financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from debt

 

 

 

 

 

 

 

40,000

 

 

 

 

 

 

 

 

 

40,000

 

Repayments of debt

 

 

 

 

(96,875

)

 

 

(40,000

)

 

 

 

 

 

 

 

 

(136,875

)

Capital lease payments

 

 

 

 

 

 

 

(950

)

 

 

 

 

 

 

 

 

(950

)

Cash contributions from member

 

 

 

 

15,544

 

 

 

 

 

 

(15,544

)

 

 

 

 

 

 

Cash distributions to member

 

(310

)

 

 

 

 

 

 

 

 

310

 

 

 

 

 

 

 

Contribution from noncontrolling interest

 

 

 

 

 

 

 

 

 

 

15,174

 

 

 

 

 

 

15,174

 

Proceeds from the exercise of stock options

 

310

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

310

 

Debt issuance costs

 

 

 

 

 

 

 

(3,310

)

 

 

(1,484

)

 

 

 

 

 

(4,794

)

Proceeds from (repayments of) intercompany loans

 

 

 

 

 

 

 

17,148

 

 

 

(97,853

)

 

 

80,705

 

 

 

 

Net cash provided by (used in) financing activities

 

 

 

 

(81,331

)

 

 

12,888

 

 

 

(99,397

)

 

 

80,705

 

 

 

(87,135

)

Effect of exchange rate differences on cash

 

 

 

 

 

 

 

 

 

 

(4,001

)

 

 

 

 

 

(4,001

)

Net decrease in cash and cash equivalents

 

 

 

 

 

 

 

(61,879

)

 

 

(72,618

)

 

 

 

 

 

(134,497

)

Cash and cash equivalents, beginning of period

 

 

 

 

 

 

 

80,903

 

 

 

142,263

 

 

 

 

 

 

223,166

 

Cash and cash equivalents, end of period

$

 

 

$

 

 

$

19,024

 

 

$

69,645

 

 

$

 

 

$

88,669

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 


38


 

    

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

INTRODUCTION

You should read the following discussion of our financial condition and results of operations with our audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K as of and for the year ended December 31, 2013. This discussion contains forward-looking statements and involves numerous risks, assumptions and uncertainties, including, but not limited to, the risk factors discussed in the “Risk Factors” section of our most recent Form 10-K, as well as in “Factors Affecting Our Results of Operations” and elsewhere in this Form 10-Q. Actual results may differ materially from those contained in any forward-looking statements.

OVERVIEW

We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability.

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than less differentiated products. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products, such as disposable diapers, and in the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as, flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms. We believe the versatility of Cariflex provides opportunities for new, high margin applications.

We have a portfolio of innovations at various stages of development and commercialization, including

polyvinyl chloride alternatives for wire and cable, and medical applications;

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

highly-modified asphalt (“HiMA”) for high-performance paving applications;

NEXAR family of membrane polymers for water filtration, heating, ventilation, air conditioning and breathable fabrics; and

synthetic cement formulations and polymers used for viscosity modification in oilfield applications.

Our products are manufactured along the following primary product lines based upon polymer chemistry and process technologies:

un-hydrogenated SBCs (“USBCs”);

hydrogenated SBCs (“HSBCs”);

Cariflex isoprene rubber (“IR”) and isoprene rubber latex (“IRL”); and

compounds.

 

39


 

The majority of worldwide SBC production is dedicated to USBCs, which are primarily used in paving and roofing, in adhesives, sealants and coatings, and in footwear applications. HSBCs, which are significantly more complex and capital-intensive to manufacture than USBCs, are primarily used in more differentiated applications, such as soft touch and flexible materials, personal hygiene products, medical products, automotive components, and certain adhesives and sealant applications.

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

Product Line Sales Revenue:

2014

 

 

2013

 

 

2014

 

 

2013

 

USBCs

 

56.0

%

 

 

57.5

%

 

 

54.6

%

 

 

57.7

%

HSBCs

 

32.8

%

 

 

31.4

%

 

 

33.0

%

 

 

31.6

%

Cariflex

 

9.0

%

 

 

8.7

%

 

 

10.2

%

 

 

8.3

%

Compounds

 

2.2

%

 

 

2.3

%

 

 

2.2

%

 

 

2.3

%

Other

 

0.0

%

 

 

0.1

%

 

 

0.0

%

 

 

0.1

%

 

 

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

End Use Markets:

2014

 

 

2013

 

 

2014

 

 

2013

 

Advanced Materials

 

25.3

%

 

 

27.2

%

 

 

25.9

%

 

 

27.8

%

Adhesives, Sealants and Coatings

 

39.6

%

 

 

37.7

%

 

 

39.6

%

 

 

38.2

%

Paving and Roofing

 

26.1

%

 

 

26.3

%

 

 

24.4

%

 

 

25.6

%

Cariflex

 

9.0

%

 

 

8.7

%

 

 

10.1

%

 

 

8.3

%

Other

 

0.0

%

 

 

0.1

%

 

 

0.0

%

 

 

0.1

%

2014 Second Quarter Financial Overview

Sales volume was 78.4 kilotons in the second quarter of 2014 compared to 77.5 kilotons in the second quarter of 2013.

Sales revenue was $323.8 million in the second quarter of 2014 compared to $334.5 million in the second quarter of 2013.

Gross profit was $72.1 million in the second quarter of 2014 compared to $59.9 million in the second quarter of 2013. Gross profit at estimated current replacement cost (“ECRC”) was $67.8 million in the second quarter of 2014 compared to $62.2 million in the second quarter of 2013.

Adjusted EBITDA was $42.9 million in the second quarter of 2014 compared to $29.7 million in the second quarter of 2013. Adjusted EBITDA at ECRC was $38.6 million in the second quarter of 2014 compared to $32.0 million in the second quarter of 2013.

Net income attributable to Kraton was $11.1 million or $0.33 per diluted share in the second quarter of 2014 compared to net income of $3.8 million or $0.12 per diluted share in the second quarter of 2013. Diluted earnings per share were impacted by items that are discussed further in Net income attributable to Kraton.


40


 

RESULTS OF OPERATIONS

Factors Affecting Our Results of Operations

Raw Materials and Product Mix. We use butadiene, styrene and isoprene as our primary raw materials in manufacturing our products and our results of operations are directly affected by the cost of these raw materials. On a FIFO basis, these monomers together represented approximately $130.6 million and $156.8 million or 51.9% and 57.1% of our total cost of goods sold for the three months ended June 30, 2014 and 2013, respectively, and approximately $258.6 million and $319.0 million or 51.1% and 57.5% of our total cost of goods sold for the six months ended June 30, 2014 and 2013, respectively. Since the cost of our three primary raw materials comprise a significant amount of our total cost of goods sold, our selling prices for our products and therefore our total sales revenue are impacted by movements in our raw material costs, as well as the cost of other inputs. In addition, product mix can have an impact on our overall unit selling prices because we provide an extensive product offering and therefore experience a wide range of unit selling prices.

The cost of these monomers has generally correlated with changes in energy prices, supply and demand factors, and prices for natural and synthetic rubber. Average purchase prices for these monomers increased during the three months ended June 30, 2014 compared to the three months ended March 31, 2014. Average purchase prices for these monomers decreased during the three and six months ended June 30, 2014 compared to the three and six months ended June 30, 2013.

We use the first-in, first-out (FIFO) basis of accounting for inventory and cost of goods sold and therefore gross profit. In periods of raw material price volatility, reported results under FIFO will differ from what the results would have been if cost of goods sold were based on ECRC. Specifically, in periods of rising raw material costs, reported gross profit will be higher under FIFO than under ECRC. Conversely, in periods of declining raw material costs, reported gross profit will be lower under FIFO than under ECRC. In recognition of the fact that the cost of raw materials affects our results of operations and the comparability of our results of operations we provide the spread between FIFO and ECRC.

In the three and six months ended June 30, 2014, reported results under FIFO were higher than results would have been on an ECRC basis by $4.3 million and $8.3 million, respectively; and

In the three and six months ended June 30, 2013, reported results under FIFO were lower than results would have been on an ECRC basis by $2.3 million and $2.8 million, respectively.

International Operations and Currency Fluctuations. We operate a geographically diverse business, serving customers in over 60 countries from five manufacturing facilities on four continents. Although we sell and manufacture our products in many countries, our sales and production costs are mainly denominated in U.S. dollars, Euro, Japanese Yen and Brazilian Real. From time to time, we use hedging strategies to reduce our exposure to currency fluctuations.

We generated our sales revenue from customers located in the following regions.

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

Revenue by Geography:

2014

 

 

2013

 

 

2014

 

 

2013

 

Americas

 

39.3

%

 

 

38.6

%

 

 

40.2

%

 

 

40.3

%

Europe, Middle East and Africa

 

38.2

%

 

 

39.4

%

 

 

36.9

%

 

 

38.3

%

Asia Pacific

 

22.5

%

 

 

22.0

%

 

 

22.9

%

 

 

21.4

%


41


 

Our financial results are subject to gains and losses on currency translations, which occur when the financial statements of our foreign operations are translated into U.S. dollars. The financial statements of operations outside the United States where the local currency is considered to be the functional currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and the average exchange rate for each period for revenues, expenses, gains and losses and cash flows. The effect of translating the balance sheet into U.S. dollars is included as a component of accumulated other comprehensive income (loss). Any appreciation of the functional currencies against the U.S. dollar will increase the U.S. dollar equivalent of amounts of revenues, expenses, gains and losses and cash flows, and any depreciation of the functional currencies will decrease the U.S. dollar amounts reported. Our results of operations are also subject to currency transaction risk. We incur currency transaction risk when we enter into either a purchase or sale transaction using a currency other than the local currency of the transacting entity. The impact from currency fluctuations amounted to pre-tax losses of $0.1 million and $0.9 million for the three months ended June 30, 2014 and 2013, respectively, and pre-tax losses of $1.5 million and $1.9 million for the six months ended June 30, 2014 and 2013, respectively. The primary driver for the increase in our pre-tax losses was the change in foreign currency exchange rates between the Brazilian Real and U.S. dollar and the Japanese Yen and U.S. dollar, for the three and six months ended June 30, 2014 and 2013, respectively.

Seasonality. Seasonal changes and weather conditions typically affect the Paving and Roofing end use market and generally result in higher sales volumes into this end use market in the second and third quarters of the calendar year compared to the first and fourth quarters of the calendar year. Our other end use markets tend to show relatively little seasonality.

Recent Developments

Combination with SBC Business of LCY. On January 28, 2014, we executed a definitive agreement to combine with the styrenic block copolymer (“SBC”) operations of Taiwan-based LCY Chemical Corp. (“LCY”). The combination agreement calls for LCY to contribute its SBC business in exchange for newly issued shares in the combined company, such that Kraton’s stockholders and LCY would each own 50% of the outstanding shares of the combined enterprise.  

On June 24, 2014, we provided an update of the first quarter 2014 results for LCY’s SBC business, which were lower than forecasted, and we provided revised financial projections for LCY’s SBC business. As a result of these financial results, the related decline in Kraton’s stock price and negative reactions from our stockholders, on June 30, 2014, we notified LCY that our Board of Directors intends to withdraw its recommendation that Kraton stockholders approve the previously announced combination agreement. Before the Kraton Board changes its recommendation Kraton was required by the combination agreement to provide LCY with at least five business days' written notice of the intention to withdraw or change its recommendation.

Our announcement of the notice to LCY stated that LCY and Kraton may engage in negotiations to determine whether they can mutually agree to changes in the terms of the combination agreement as would enable the Kraton Board to continue to recommend the transaction to Kraton stockholders. Kraton cannot predict whether any such negotiations will result in mutually agreeable changes to the combination agreement. Kraton does not intend to make further public comment regarding the status of any such negotiations unless and until the parties enter into an amendment to the combination agreement effecting such changes, or unless and until Kraton determines that any such negotiations have been abandoned. In either such event, such process may take longer than the minimum five business days provided in the combination agreement.  The combination agreement will remain in effect unless and until it is terminated in accordance with its terms.

KFPC loan agreement. On July 17, 2014, KFPC executed a syndicated loan agreement (the “KFPC Loan Agreement”) in the amount of 5.5 billion New Taiwan Dollars (“NTD”), or $182.9 million (converted at the July 17, 2014 exchange rate), to provide additional funding to construct the HSBC facility in Taiwan and to provide funding for working capital requirements and/or general corporate purposes. The KFPC Loan Agreement is comprised of  NTD 4.29 billion, or $142.7 million (converted at the July 17, 2014 exchange rate), to fund KFPC’s capital expenditures, and NTD 1.21 billion, or $40.2 million (converted at the July 17, 2014 exchange rate), to fund working capital requirements and/or general corporate purposes. Obligations under the KFPC Loan Agreement are guaranteed 50% by Formosa Petrochemical Corporation and 50% by Kraton Polymers LLC. See Note 16. Subsequent Events, for further discussion.

42


 

Outlook

We currently estimate that our results in the third quarter of 2014 will reflect a negative spread between FIFO and ECRC of approximately $1.0 million.

 

Three Months Ended June 30, 2014 Compared to Three Months Ended June 30, 2013

Sales Revenue

Sales revenue was $323.8 million on sales volumes of 78.4 kilotons for the three months ended June 30, 2014 compared to $334.5 million on sales volumes of 77.5 kilotons for the three months ended June 30, 2013. Sales revenue declined $10.8 million or 3.2% compared to the second quarter 2013, with $21.8 million of the decrease attributable to a reduction in product sales prices associated with lower average raw material costs, partially offset by $6.6 million resulting from higher sales volumes and $4.6 million positive effect from currency fluctuations.

With respect to sales revenue in each of our end use markets:

Advanced Materials sales revenue was $81.7 million for the three months ended June 30, 2014 compared to $91.1 million for the three months ended June 30, 2013. The $9.5 million or 10.4% revenue decline (a decline of $10.5 million or 11.5% excluding a $1.1 million positive effect from currency fluctuations) was largely due to a 5.6% decline in sales volumes and lower average selling prices reflective of lower raw material costs, primarily butadiene. The decline in sales volume was due to lower volume into personal care applications, reflecting the market trend in the diaper business as certain customers shift from HSBC-based applications towards less differentiated and lower cost materials. HSBC sales volumes in personal care applications for the three months ended June 30, 2014 decreased approximately one kiloton as compared to the three months ended June 30, 2013. We believe the shift away from HSBC solutions in personal care applications has largely occurred. Partially offsetting the decline in personal care sales volumes was an increase in sales volumes into HSBC-based PVC replacement products, specifically into highly-differentiated, innovation grades in medical and wire and cable applications. We also realized sales volume growth in other innovation applications such as USBC-based personal care, and consumer and automotive & industrial applications.

Adhesives, Sealants and Coatings sales revenue was $128.2 million for the three months ended June 30, 2014 compared to $126.0 million for the three months ended June 30, 2013. The $2.1 million or 1.7% revenue increase (an increase of $1.1 million or 0.8% excluding a $1.1 million positive effect from currency fluctuations) was primarily due to a 5.9% increase in sales volumes partially offset by lower average selling prices, reflective of lower raw material costs, primarily butadiene and isoprene. The increase in sales volumes was primarily due to higher HSBC-based sales into lubricant additive and sealant and caulk applications and higher USBC-based sales into industrial and printing plate applications.

Paving and Roofing sales revenue was $84.6 million for the three months ended June 30, 2014 compared to $87.8 million for the three months ended June 30, 2013. The $3.3 million or 3.7% revenue decline (a decline of $4.9 million or 5.6% excluding a $1.7 million positive effect from currency fluctuations) was largely due to lower average selling prices reflective of lower raw material costs, primarily butadiene, with a modest increase in sales volumes. Sales volumes in North American paving applications improved significantly for the three months ended June 30, 2014 compared to relatively low sales volumes in the three months ended June 30, 2013, which was impacted by poor weather conditions, with higher North American sales volumes partially offset by lower paving sales volumes in Asia and lower roofing sales volumes in Europe. For the three months ended June 30, 2014, growth in HiMA sales volumes continued, led by increased sales in South America compared to the three months ended June 30, 2013.

CariflexTM sales revenue was $29.2 million for the three months ended June 30, 2014 and June 30, 2013. Excluding the positive effect of currency fluctuations, sales revenue for the three months ended June 30, 2014 would have been down $0.8 million compared to the three months ended June 30, 2013, with a modest improvement in sales volume which was more than offset by lower average selling prices, primarily due to lower isoprene costs.

43


 

Cost of Goods Sold

Cost of goods sold was $251.7 million for the three months ended June 30, 2014 compared to $274.7 million for the three months ended June 30, 2013. The $23.0 million or 8.4% decrease was driven largely by a $30.4 million reduction in raw material costs, partially offset by the effect of higher sales volumes of $3.6 million and currency fluctuations of $2.1 million.

Gross Profit

Gross profit was $72.1 million for the three months ended June 30, 2014 compared to $59.9 million for the three months ended June 30, 2013, an increase of $12.2 million or 20.4%. The positive effect from lower costs of raw materials aggregating $30.4 million more than offset the $21.8 million decline in product sales prices associated with lower average raw material costs, which amounted to an increase in gross profit of $8.6 million, and increased sales volumes amounted to an additional $3.0 million increase in gross profit. In addition, increases in other manufacturing costs were essentially offset by favorable manufacturing absorption and currency fluctuations. Gross profit as a percentage of sales revenue was 22.3% and 17.9% for the three months ended June 30, 2014 and 2013, respectively.  Adjusting for the $4.3 million positive spread between FIFO and ECRC in the second quarter 2014 and the negative spread of $2.3 million in the second quarter 2013, gross profit at ECRC was $67.8 million in the second quarter 2014 compared to $62.2 million in the second quarter 2013.

Operating Expenses

Research and Development. Research and development expenses were $8.0 million for the three months ended June 30, 2014 compared to $8.4 million for the three months ended June 30, 2013, a decrease of $0.4 million or 5.3%. Research and development expenses were 2.5% of sales revenue for the three months ended June 30, 2014 and 2013.

Selling, General and Administrative. Selling, general and administrative expenses were $28.3 million for the three months ended June 30, 2014 compared to $25.0 million for the three months ended June 30, 2013, an increase of $3.3 million or 13.1% primarily due to a $2.8 million increase in professional fees and other costs related to the proposed combination with the SBC Business of LCY and $0.6 million in employee related costs. Selling, general and administrative expenses were 8.7% and 7.5% of sales revenue for the three months ended June 30, 2014 and 2013, respectively.

Depreciation and Amortization. Depreciation and amortization was $16.7 million for the three months ended June 30, 2014 compared to $15.7 million for the three months ended June 30, 2013, an increase of $0.9 million or 5.9%.

Interest expense, net

Interest expense, net was $6.2 million for the three months ended June 30, 2014 compared to $5.9 million for the three months ended June 30, 2013, an increase of $0.3 million or 5.4%.  

Income tax expense

Income tax expense was $2.2 million and $0.9 million for the three months ended June 30, 2014 and 2013, respectively.  Our effective tax rate was 16.6% and 18.5% for the three months ended June 30, 2014 and 2013, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and changes in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion, or all, of our deferred tax assets will not be realized. As of June 30, 2014 and December 31, 2013, a valuation allowance of $89.8 million and $90.0 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We decreased our valuation allowance by $0.7 million and $3.1 million for the three months ended June 30, 2014 and 2013, respectively, which represents the utilization of net operating losses. Excluding the change in our valuation allowance, our effective tax rate would have been 21.7% and 81.1% for the three months ended June 30, 2014 and 2013, respectively.

Net income attributable to Kraton

Net income attributable to Kraton was $11.1 million or $0.33 per diluted share for the three months ended June 30, 2014, an increase of $7.3 million compared to net income of $3.8 million or $0.12 per diluted share for the three months ended June 30, 2013.

44


 

Net income for the three months ended June 30, 2014 included the following items, net of tax:

Fees related to the proposed combination with the SBC Business of LCY of $3.8 million or $0.11 per diluted share

Start-up charges related to the joint venture with FPCC of $0.2 million or $0.01 per diluted share, partially offset by a

Positive spread between FIFO and ECRC of $4.3 million or $0.13 per diluted share

Net income for the three months ended June 30, 2013 included the following items, net of tax:

Transaction and acquisition related costs of $1.1 million or $0.03 per diluted share

Negative spread between FIFO and ECRC of $2.5 million or $0.08 per diluted share

Six Months Ended June 30, 2014 Compared to Six Months Ended June 30, 2013

Sales Revenue

Sales revenue was $635.4 million on sales volumes of 152.8 kilotons for the six months ended June 30, 2014 compared to $674.7 million on sales volumes of 155.7 kilotons for the six months ended June 30, 2013. Sales revenue declined $39.2 million or 5.8% compared to sales revenue for the six months ended June 30, 2013, with $40.6 million of the decrease attributable to a reduction in product sales prices associated with lower average raw material costs and $2.7 million resulting from lower sales volumes, partially offset by $4.5 million positive effect from currency fluctuations.

With respect to sales revenue in each of our end use markets:

Advanced Materials sales revenue was $164.4 million for the six months ended June 30, 2014 compared to $187.7 million for the six months ended June 30, 2013. The $23.4 million or 12.4% revenue decline (a decline of $24.9 million or 13.3% excluding a $1.6 million positive effect from currency fluctuations) was largely due to a 7.5% decline in sales volumes  and, to a lesser extent, lower average selling prices reflective of lower raw material costs, primarily butadiene. The decline in sales volume was primarily due to lower volume into personal care applications, reflecting the market trend in the diaper business as certain customers shift from HSBC-based applications towards less differentiated and lower cost materials. HSBC sales volumes in personal care applications for the six months ended June 30, 2014 decreased approximately two kilotons as compared to the six months ended June 30, 2013. We believe the shift away from HSBC solutions in personal care applications has largely occurred. Partially offsetting the decline in personal care sales volumes was an increase in sales volumes into HSBC-based PVC replacement products, specifically into highly-differentiated, innovation grades in medical and wire and cable applications. We also realized sales volume growth in other innovation applications such as USBC-based personal care, and consumer and automotive & industrial applications for the six months ended June 30, 3014 compared to the six months ended June 30, 2013.

Adhesives, Sealants and Coatings sales revenue was $251.4 million for the six months ended June 30, 2014 compared to $257.5 million for the six months ended June 30, 2013. The $6.1 million or 2.4% revenue decline (a decline of $6.4 million or 2.5% excluding a $0.3 million positive effect from currency fluctuations) was primarily due to lower average selling prices, reflective of lower raw material costs of $9.0 million partially offset by a 1.2% increase in sales volumes. The increase in sales volumes was primarily due to higher sales into lubricant additive, sealant & caulk and printing plate applications partially offset by lower sales into pressure sensitive adhesive and industrial applications.

Paving and Roofing sales revenue was $154.8 million for the six months ended June 30, 2014 compared to $172.5 million for the six months ended June 30, 2013. The $17.7 million or 10.3% revenue decline (a decline of $19.5 million or 11.3% excluding a $1.8 million positive effect from currency fluctuations) was largely due to lower average selling prices, reflective of lower raw material costs, primarily butadiene and, to a lesser extent, a 3.1% decline in sales volumes. Increased sales volumes in roofing applications partially offset lower sales volume in paving applications. Innovation sales volumes were down with increased sales of paving applications such as HiMA largely offsetting lower sales in roofing applications.

45


 

CariflexTM sales revenue was $64.6 million for the six months ended June 30, 2014 compared to $56.3 million for the six months ended June 30, 2013. The $8.3 million or 14.8% revenue increase (an increase of $7.5 million or 13.4% excluding a $0.8 million positive effect from currency fluctuations) was primarily due to a 17.8% increase in sales volumes, mainly in the surgical glove and condom markets which was partially offset by lower average selling prices, primarily due to lower isoprene costs and sales mix.


46


 

Cost of Goods Sold

Cost of goods sold was $506.3 million for the six months ended June 30, 2014 compared to $554.9 million for the six months ended June 30, 2013. The $48.6 million or 8.8% decrease was driven largely by a $57.0 million reduction in raw material costs and the effect of lower sales volumes of $8.1 million, partially offset by currency fluctuations of $6.1 million and higher costs including $12.4 million associated with the weather-related production downtime at our Belpre, Ohio facility and an operating disruption from a small fire at our Berre, France facility in the first quarter of 2014.

Gross Profit

Gross profit was $129.2 million for the six months ended June 30, 2014 compared to $119.8 million for the six months ended June 30, 2013, an increase of $9.4 million or 7.8%. The positive effect from lower costs of raw materials aggregating $57.0 million more than offset the $40.6 million decline in product sales prices associated with lower average raw material costs, which amounted to an increase in gross profit of $16.4 million, and increased sales volumes amounted to an additional $5.4 million increase in gross profit. Gross profit was negatively impacted by $12.4 million associated with the production downtime. In addition, increases in other manufacturing costs and the negative effect from currency fluctuations were essentially offset by favorable manufacturing absorption. Gross profit as a percentage of sales revenue was 20.3% and 17.8% for the six months ended June 30, 2014 and 2013, respectively. Adjusting for the $8.3 million positive spread between FIFO and ECRC for the six months ended June 30, 2014 and the negative spread of $2.8 million for the six months ended June 30, 2013, gross profit at ECRC was $120.8 million for the six months ended June 30, 2014 compared to $122.6 million for the six months ended June 30, 2013.

Operating Expenses

Research and Development. Research and development expenses were $16.3 million for the six months ended June 30, 2014 compared to $16.4 million for the six months ended June 30, 2013, a decrease of $0.1 million or 0.4%. Research and development expenses were 2.6% and 2.4% of sales revenue for the six months ended June 30, 2014 and 2013, respectively.

Selling, General and Administrative. Selling, general and administrative expenses were $62.5 million for the six months ended June 30, 2014 compared to $51.1 million for the six months ended June 30, 2013, an increase of $11.4 million or 22.3% primarily due to a $11.9 million increase in professional fees and other costs related to the proposed combination with the SBC Business of LCY and $0.6 million in costs related to production downtime at our Belpre, Ohio facility, partially offset by a $0.8 million decrease in costs related to our joint venture company, KFPC. Selling, general and administrative expenses were 9.8% and 7.6% of sales revenue for the six months ended June 30, 2014 and 2013, respectively.

Depreciation and Amortization. Depreciation and amortization was $33.1 million for the six months ended June 30, 2014 compared to $30.8 million for the six months ended June 30, 2013, an increase of $2.2 million or 7.3% due to capital expenditures.

Interest expense, net

Interest expense, net was $12.6 million for the six months ended June 30, 2014 compared to $19.2 million for the six months ended June 30, 2013, a decrease of $6.6 million or 34.6%. The decrease was primarily due to charges aggregating $5.7 million incurred in connection with our March 2013 refinancing and to lower outstanding indebtedness.  

Income tax expense

Income tax expense was $2.3 million and $2.4 million for the six months ended June 30, 2014 and 2013, respectively. Our effective tax rate was 46.1% and 93.9% for the six months ended June 30, 2014 and 2013, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and changes in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion, or all, of our deferred tax assets will not be realized. As of June 30, 2014 and December 31, 2013, a valuation allowance of $89.8 million and $90.0 million, respectively, has

47


 

been provided for net operating loss carryforwards and other deferred tax assets. We decreased our valuation allowance by $0.2 million for the six months ended June 30, 2014, primarily due to the utilization of net operating losses. We increased our valuation allowance by $4.3 million for the six months ended June 30, 2013, of which $4.5 million represents current period net operating losses, partially offset by $0.2 million which represents changes in other comprehensive income (loss). Excluding the change in our valuation allowance, our effective tax rate would have been 50.2% and an 88.1% benefit for the six months ended June 30, 2014 and 2013, respectively.

Net income attributable to Kraton

Net income attributable to Kraton was $3.2 million or $0.10 per diluted share for the six months ended June 30, 2014, an increase of $3.2 million compared to net income of $0.1 million or $0.00 per diluted share for the six months ended June 30, 2013.

Net income for the six months ended June 30, 2014 included the following items, net of tax:

Restructuring and other charges of $0.5 million or $0.02 per diluted share

Fees related to the proposed combination with the SBC Business of LCY of $13.0 million or $0.39 per diluted share

Production downtime at our Belpre, Ohio and Berre, France facilities of $13.0 million or $0.39 per diluted share

Start-up charges related to the joint venture with FPCC of $0.4 million or $0.01 per diluted share, partially offset by a

Positive spread between FIFO and ECRC of $8.3 million or $0.25 per diluted share

Net income for the six months ended June 30, 2013 included the following items, net of tax:

Transaction and acquisition related costs of $1.1 million or $0.04 per diluted share

Charges associated with the credit facility refinancing of $5.7 million or $0.18 per diluted share

Negative spread between FIFO and ECRC of $3.2 million or $0.10 per diluted share

Critical Accounting Policies

For a discussion of our critical accounting policies and estimates that require the use of significant estimates and judgments, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2013.

 

 


48


 

EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC

We consider EBITDA, Adjusted EBITDA, Adjusted EBITDA at estimated current replacement cost (ECRC), Gross Profit at ECRC and Adjusted Gross Profit at ECRC to be important supplemental measures of our performance and believe they are frequently used by investors, securities analysts and other interested parties in the evaluation of our performance including period-to-period comparisons and/or that of other companies in our industry. In addition, management uses these measures to evaluate operating performance, and our incentive compensation plan bases incentive compensation payments on our Adjusted EBITDA at ECRC performance, along with other factors. EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC, Gross Profit at ECRC and Adjusted Gross Profit at ECRC have limitations as analytical tools and in some cases can vary substantially from other measures of our performance. You should not consider any of them in isolation, or as substitutes for analysis of our results under U.S. generally accepted accounting principles (“GAAP”).

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

EBITDA (1)

$

35,928

 

 

$

26,532

 

 

$

50,603

 

 

$

52,550

 

Adjusted EBITDA (2)

$

42,880

 

 

$

29,663

 

 

$

84,398

 

 

$

58,340

 

Adjusted EBITDA at ECRC (3)

$

38,580

 

 

$

31,967

 

 

$

76,074

 

 

$

61,151

 

Gross Profit at ECRC (3)

$

67,780

 

 

$

62,165

 

 

$

120,829

 

 

$

122,583

 

Adjusted Gross Profit at ECRC (3)

$

67,780

 

 

$

62,165

 

 

$

133,242

 

 

$

122,583

 

 

 

(1)

EBITDA represents net income before interest, taxes, depreciation and amortization.

      

Limitations for EBITDA as an analytical tool include the following:

EBITDA does not reflect the significant interest expense on our debt;

EBITDA does not reflect the significant depreciation and amortization expense associated with our long-lived assets;

EBITDA included herein should not be used for purposes of assessing compliance or non-compliance with financial covenants under our debt agreements.  The calculation of EBITDA in the debt agreements includes adjustments, such as extraordinary, non-recurring or one-time charges, proforma cost savings, certain non-cash items, turnaround costs, and other items included in the definition of EBITDA in the debt agreements; and

Other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure.

(2)

We prepare Adjusted EBITDA by adjusting EBITDA to eliminate the impact of a number of items we do not consider indicative of our ongoing operating performance. We explain how each adjustment is derived and why we believe it is helpful and appropriate in the reconciliation below. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. As an analytical tool, Adjusted EBITDA is subject to the limitations applicable to EBITDA described above. In addition, in evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

(3)

Adjusted EBITDA at ECRC is Adjusted EBITDA net of the impact of the spread between the FIFO basis of accounting and ECRC, Gross Profit at ECRC is gross profit net of the impact of the spread between the FIFO basis of accounting and ECRC and Adjusted Gross Profit at ECRC is Gross Profit at ECRC net of the impact of a number of items we do not consider indicative of our ongoing operating performance. Although we report our financial results using the FIFO basis of accounting, as part of our pricing strategy, we measure our business performance using the estimated current replacement cost of our inventory and cost of goods sold. We maintain our perpetual inventory in our global enterprise resource planning system, where the carrying value of our inventory is determined using FIFO. At the beginning of each month, we determine the estimated current cost of our raw materials for that particular month, and using the same perpetual inventory system that we use to manage inventory and therefore costs of goods sold under FIFO, we revalue our ending inventory to reflect the total cost of such inventory as if it was valued using the estimated current replacement cost. The result of this revaluation from FIFO creates the spread between FIFO and ECRC. With inventory valued under FIFO and ECRC, we then have the ability to report cost of goods sold and therefore EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC, Gross Profit, Gross Profit at ECRC, and Adjusted

49


 

Gross Profit at ECRC under both our FIFO convention and under estimated current replacement cost. As an analytical tool, Adjusted EBITDA at ECRC is subject to the limitations applicable to EBITDA described above, as well as the following limitations:

due to volatility in raw material prices, Adjusted EBITDA at ECRC may, and often does, vary substantially from EBITDA, net income and other performance measures, including net income calculated in accordance with US GAAP; and

Adjusted EBITDA at ECRC may, and often will, vary significantly from EBITDA calculations under the terms of our debt agreements and should not be used for assessing compliance or non-compliance with financial covenants under our debt agreements.

Because of these and other limitations, EBITDA, Adjusted EBITDA and Adjusted EBITDA at ECRC should not be considered as a measure of discretionary cash available to us to invest in the growth of our business.

Our presentation of non-GAAP financial measures and the adjustments made therein should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, and in the future we may incur expenses or charges similar to the adjustments made in the presentation of our non-GAAP financial measures.

As a measure of our performance, Gross Profit at ECRC and Adjusted Gross Profit at ECRC are limited because they often vary substantially from gross profit calculated in accordance with US GAAP due to volatility in raw material prices.

We compensate for these limitations by relying primarily on our GAAP results and using EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC, Gross Profit at ECRC, and Adjusted Gross Profit at ECRC only as supplemental measures. See our financial statements included elsewhere in this Form 10-Q.

We reconcile Gross Profit to Gross Profit at ECRC and Adjusted Gross Profit at ECRC as follows:

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

Gross profit

$

72,080

 

 

$

59,861

 

 

$

129,153

 

 

$

119,772

 

Add (deduct):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Spread between FIFO and ECRC

 

(4,300

)

 

 

2,304

 

 

 

(8,324

)

 

 

2,811

 

Gross profit at ECRC

 

67,780

 

 

 

62,165

 

 

 

120,829

 

 

 

122,583

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Production downtime (a)

 

 

 

 

 

 

 

12,413

 

 

 

 

Adjusted gross profit at ECRC

$

67,780

 

 

$

62,165

 

 

$

133,242

 

 

$

122,583

 

 

 

(a)Production downtime at our Belpre, Ohio and Berre, France facilities.


50


 

We reconcile consolidated net income to EBITDA, Adjusted EBITDA and Adjusted EBITDA at ECRC as follows:

 

 

Three months ended

June 30,

 

 

Six months ended

June 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

 

(In thousands)

 

 

(In thousands)

 

Net income attributable to Kraton

$

11,143

 

 

$

3,829

 

 

$

3,234

 

 

$

81

 

Net income (loss) attributable to noncontrolling interest

 

(275

)

 

 

148

 

 

 

(560

)

 

 

72

 

Consolidated net income

 

10,868

 

 

 

3,977

 

 

 

2,674

 

 

 

153

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

6,230

 

 

 

5,909

 

 

 

12,568

 

 

 

19,207

 

Income tax expense

 

2,161

 

 

 

905

 

 

 

2,283

 

 

 

2,351

 

Depreciation and amortization expenses

 

16,669

 

 

 

15,741

 

 

 

33,078

 

 

 

30,839

 

EBITDA

 

35,928

 

 

 

26,532

 

 

 

50,603

 

 

 

52,550

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and other charges (a)

 

132

 

 

 

73

 

 

 

653

 

 

 

128

 

Transaction and acquisition related costs (b)

 

3,807

 

 

 

1,051

 

 

 

13,043

 

 

 

1,132

 

Production downtime (c)

 

 

 

 

 

 

 

13,013

 

 

 

 

Asia JV (d)

 

433

 

 

 

 

 

 

892

 

 

 

 

Non-cash compensation expense (e)

 

2,580

 

 

 

2,007

 

 

 

6,194

 

 

 

4,530

 

Adjusted EBITDA

 

42,880

 

 

 

29,663

 

 

 

84,398

 

 

 

58,340

 

Add (deduct):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Spread between FIFO and ECRC

 

(4,300

)

 

 

2,304

 

 

 

(8,324

)

 

 

2,811

 

Adjusted EBITDA at ECRC

$

38,580

 

 

$

31,967

 

 

$

76,074

 

 

$

61,151

 

 

 

 

(a)

Severance expenses which are primarily recorded in cost of goods sold in 2014 and in selling, general and administrative expenses in 2013.  

(b)

Primarily professional fees related to our proposed combination with the styrenic block copolymer business of LCY Chemical Corp., which are recorded in selling, general and administrative expenses.

(c)

Production downtime at our Belpre, Ohio and Berre, France facilities, of which, $12.4 million is recorded in cost of goods sold and $0.6 million is recorded in selling, general and administrative expenses.

(d)

Startup costs related to the joint venture company, KFPC, which are recorded in selling, general and administrative expenses.

(e)

For the three and six months ended June 30, 2014, $2.2 million and $5.3 million is recorded in selling, general and administrative expenses, $0.2 million and $0.5 million is recorded in research and development expenses, and $0.2 million and $0.4 million is recorded in cost of goods sold. Prior to the second quarter of 2013, all non-cash compensation expenses were recorded in selling, general and administrative expenses. For the three and six months ended June 30, 2013, $1.7 million and $4.2 million is recorded in selling, general and administrative expenses, $0.2 million and $0.2 million is recorded in research and development expenses, and $0.1 million and $0.1 million is recorded in cost of goods sold.

 

51


 

LIQUIDITY AND CAPITAL RESOURCES

Known Trends and Uncertainties

Kraton Performance Polymers, Inc. is a holding company without any operations or assets other than the operations of its subsidiaries. Cash flows from operations of our subsidiaries, cash on hand and available borrowings under our credit facility are our principal sources of liquidity.

In March 2013, we entered into an asset-based revolving credit facility consisting of a U.S. senior secured revolving credit facility of $150.0 million and a Dutch senior secured revolving credit facility of $100.0 million (the “Senior Secured Credit Facilities”), to replace our then-existing senior secured credit facility, and repaid in full all outstanding amounts payable under the previously existing facility.

The Senior Secured Credit Facilities are principally secured by receivables and inventory, and borrowing availability under the facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security. The Senior Secured Credit Facilities include a $100.0 million uncommitted accordion feature that, subject to borrowing base availability and approval of the bank syndicate, could increase aggregate availability to $350.0 million. We cannot guarantee that all of the lending counterparties contractually committed to fund a revolving credit draw request will actually fund future requests, although we currently believe that each of the counterparties would meet their funding requirements. The Senior Secured Credit Facilities terminate on March 27, 2018; however we may, from time to time, request that the lenders extend the maturity of their commitments; provided that at no time shall there be more than four maturity dates under the Senior Secured Credit Facilities.

The Senior Secured Credit Facilities contain a financial covenant requiring us to maintain a fixed charge coverage ratio of 1.0 to 1.0 if availability under the facilities is below specified amounts. Our failure to comply with this financial maintenance covenant would give rise to a default under the Senior Secured Credit Facilities. If factors arise that negatively impact our profitability, we may not be able to satisfy this covenant. In addition, the Senior Secured Credit Facilities contain customary events of default, including, without limitation, a failure to make payments under the facilities, cross-default with respect to other indebtedness and cross-judgment default, certain bankruptcy events and certain change of control events. If we are unable to satisfy the covenants or other provisions of the Senior Secured Credit Facilities at any future time we would need to seek an amendment or waiver of such covenants or other provisions. The respective lenders under the Senior Secured Credit Facilities may elect not to consent to any amendment or waiver requests that we may make in the future, and, if they do consent, they may do so on terms that are not favorable to us. In the event that we are unable to obtain any such waiver or amendment and we are not able to refinance or repay our Senior Secured Credit Facilities, our inability to meet the covenants or other provisions of the Senior Secured Credit Facilities would constitute an event of default, which would permit the bank lenders to accelerate the Senior Secured Credit Facilities. Such acceleration may in turn constitute an event of default under our senior notes or other indebtedness.

Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019. The notes are general unsecured, senior obligations and are unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year. Prior to March 1, 2015, we may redeem all or a part of the senior notes, at a redemption price equal to 100.00% of the principal amount of the senior notes redeemed plus the applicable premium as of such date, plus accrued and unpaid interest, if any, to the applicable redemption date. After March 1, 2015, we may redeem all or a part of the senior notes for 103.375%, 101.688%, and 100.000% of the principal amount in 2015, 2016 and 2017 and thereafter, respectively.

Consummation of the proposed transaction with LCY would constitute a change of control under the indenture governing our 6.75% senior notes, which would result in an event of default under the Senior Secured Credit Facilities. Under the combination agreement with LCY, it is a condition to the parties’ obligations to close the transaction that we obtain the necessary consent such that the combination with the SBC business of LCY will not result in an event of default under our Senior Secured Credit Facilities. If the transaction with LCY proceeds, we intend to seek the consent of our bond holders such that the combination with the SBC business would not constitute a change of control under the indenture and to satisfy the closing condition.

At June 30, 2014, we were in compliance with the covenants under the Senior Secured Credit Facilities and the indenture governing our 6.75% senior notes.

52


 

Based upon current and anticipated levels of operations, we believe that cash flows from operations of our subsidiaries, cash on hand, and borrowings available to us will be sufficient to fund our expected financial obligations, planned capital expenditures and anticipated liquidity requirements, including working capital requirements, our investment in the joint venture with FPCC, debt payments, interest payments, benefit plan contributions and income tax obligations. However, these cash flows are subject to a number of risks and uncertainties, including, but not limited to, earnings, sensitivities to the cost of raw materials, seasonality and fluctuations in foreign currency exchange rates. Because feedstock costs generally represent a substantial portion of our cost of goods sold, in periods of rising feedstock costs, we generally consume cash in operating activities due to increases in accounts receivable and inventory costs, partially offset by increased value of accounts payable. Conversely, during periods in which feedstock costs are declining, we generate cash flow from decreases in working capital. Additionally, our combination agreement with LCY contains restrictions on our incurrence of indebtedness, subject to specified exceptions that include borrowings under the Senior Secured Credit Facilities in the ordinary course.  If we needed borrowings in excess of $10.0 million above what is available to us under the Senior Secured Credit Facilities and LCY did not provide its consent, our ability to fund our financial obligations may be adversely affected.

Going forward there can be no assurance that our business will generate sufficient cash flow from operations or that future borrowings will be available under our senior secured credit facilities to fund liquidity needs and enable us to service our indebtedness. At June 30, 2014, we had $65.9 million of cash and cash equivalents, which includes $36.5 million of cash-on-hand at KFPC, the consolidated joint venture in Asia. As of June 30, 2014, our available borrowing capacity was $231.8 million of which $0.0 million was drawn and as of the date of this filing, our available borrowing capacity was $231.9 million, of which $0.0 million was drawn. Excluding the $36.5 million of KFPC cash, our liquidity at June 30, 2014 amounted to $261.2 million. Our available cash and cash equivalents are held in accounts managed by third-party financial institutions and consist of cash invested in interest bearing funds and operating accounts. To date, we have not experienced any losses or lack of access to our invested cash or cash equivalents; however, we cannot provide any assurance that adverse conditions in the financial markets will not impact access to our invested cash and cash equivalents.

For additional information regarding our Senior Secured Credit Facilities and our 6.75% Senior Notes, see “—Senior Secured Credit Facilities and 6.75% Senior Notes due in 2019—” in Note 6 Long-Term Debt to the condensed consolidated financial statements, which is incorporated herein by reference.

We made contributions of $3.0 million to our pension plan in the six months ended June 30, 2014 and $2.6 million in the six months ended June 30, 2013. We expect our total pension plan contributions for the year ending December 31, 2014 to be $7.2 million. Our pension plan obligations are predicated on a number of factors, the primary ones being the return on our pension plan assets and the discount rate used in deriving our pension obligations. If the investment return on our pension plan assets does not meet or exceed expectations during 2014, and the discount rate decreases from the prior year, higher levels of contributions could be required in 2015 and beyond.

As of June 30, 2014, we had $63.2 million of cash and short-term investments related to foreign operations that management asserts are permanently reinvested. As a result of net operating loss carryforwards, management estimates that no additional cash tax expense would be incurred if this cash were repatriated.

Turbulence in U.S. and international markets and economies may adversely affect our liquidity and financial condition, the liquidity and financial condition of our customers, and our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations. However, to date we have been able to access borrowings available to us in amounts sufficient to fund liquidity needs. Total receivables, net of allowances, for customers located in Italy, Spain, Portugal, Greece and Ireland aggregated approximately $6.2 million at June 30, 2014. We have not incurred to date, nor do we currently expect to incur any material losses associated with these trade receivables.

Our ability to pay principal and interest on our indebtedness, fund working capital, make anticipated capital expenditures and fund our investment in the joint venture with FPCC depends on our future performance, which is subject to general economic conditions and other factors, some of which are beyond our control. “See Part I, Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 for further discussion.


53


 

Operating Cash Flows and Liquidity

Due to the seasonal nature of portions of our business, we generally use cash in operating activities in the first half of the year. In the six months ended June 30, 2014 and 2013, cash used in operating activities totaled $51.6 million and $4.4 million, respectively. The decline in operating cash flow of $47.1 million in the first half of 2014 compared to the first half of 2013 was primarily the result of the timing of payments of current liabilities and an increase in inventories, partially offset by the timing of receivables and revenue per ton, which resulted in a smaller increase in accounts receivable in 2014 as compared to 2013.

Investing Cash Flows

Net cash used in investing activities totaled $54.8 million for the six months ended June 30, 2014 and $38.9 million for the six months ended June 30, 2013, which includes $22.5 million and $5.8 million, respectively, related to capital expenditures incurred by KFPC, our 50/50 joint venture with FPCC.

Expected Capital Expenditures. We currently expect 2014 capital expenditures, excluding capital expenditures by the joint venture with FPCC, will be approximately $75.0 million to $80.0 million. Included in this estimate is approximately $30.5 million to comply with the boiler MACT regulations, and approximately $16.0 million to $22.0 million for health, safety and environmental and infrastructure and maintenance projects. The remaining anticipated 2014 capital expenditures are primarily associated with projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform.

We currently anticipate the total FPCC joint venture project construction cost will be at least $200.0 million; of which, 2014 capital expenditures will be approximately $70.0 million to $75.0 million. The project will be funded with a combination of equity and debt financing. From the inception of the project to June 30, 2014, we and FPCC have each made equity investments of $41.6 million to KFPC. On July 17, 2014, KFPC executed a syndicated loan agreement in the amount of 5.5 billion New Taiwan Dollars, or $182.9 million (converted at the July 17, 2014 exchange rate), to provide the debt portion of the project financing including funding for working capital and/or general corporate purposes. Kraton Polymers LLC and FPCC are guarantors of the loan agreement with each guaranteeing fifty percent of the indebtedness. See Note 16 Subsequent Events, for further discussion.

Financing Cash Flows

Our consolidated capital structure as of June 30, 2014 and December 31, 2013 was approximately 57% equity, 39% debt and 4% noncontrolling interest.

Net cash used in financing activities totaled $4.1 million for the six months ended June 30, 2014 compared to net cash used in financing activities of $87.1 million for the six months ended June 30, 2013. In the six months ended June 30, 2013, we repaid $96.9 million remaining principal balance of term loans and received $15.2 million from FPCC, which represents their portion of the equity investment in the joint venture.  

Contractual Commitments

Our contractual obligations are summarized in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our annual report on Form 10-K for the year ended December 31, 2013.There have been no material changes to the contractual obligation amounts disclosed in our annual report on Form 10-K for the year ended December 31, 2013.

Off-Balance Sheet Arrangements

We are not involved in any material off-balance sheet arrangements as of June 30, 2014, other than operating leases.

 

 

 

54


 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk.

For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our annual report on Form 10-K for the year ended December 31, 2013. There have been no material changes to the quantitative and qualitative disclosures about market risk disclosed in our annual report on Form 10-K for the year ended December 31, 2013. See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for further discussion.

 

Item 4.

Controls and Procedures.

An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934) was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. As of June 30, 2014, based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective.

There has been no change in our internal control over financial reporting that occurred during the three months ended June 30, 2014 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

55


 

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings.

For information regarding legal proceedings, see Note 10 Commitments and Contingencies, to our condensed consolidated financial statements.

In January 2014, our Belpre, Ohio facility experienced a mechanical equipment failure due to inclement weather that resulted in a release of process solvents into nearby waterways.

 

Item 1A.

Risk Factors.

Readers of this Quarterly Report on Form 10-Q should carefully consider the risks described in our other reports and filings filed with or furnished to the SEC, including our prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of our financial position, results of operations and cash flows.

The risks and uncertainties in our most recent Annual Report on Form 10-K, are not the only risks that we face. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect our operations. Any of the risks, uncertainties, events or circumstances described therein could cause our future financial condition, results of operations or cash flows to be adversely affected.

 

 

 

56


 

Item 6.

Exhibits.

 

Exhibit
Number

 

 

10.1*

 

Guarantee Agreement, dated as of July 17, 2014

31.1*

 

Certification of Chief Executive Officer under Section 302 of Sarbanes—Oxley Act of 2002

31.2*

 

Certification of Chief Financial Officer under Section 302 of Sarbanes—Oxley Act of 2002

32.1*

 

Certification Pursuant to Section 906 of Sarbanes—Oxley Act of 2002

101*

 

The following materials from Kraton Performance Polymers, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of June 30, 2014 and December 31, 2013 (Unaudited), (ii) Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2014 and 2013 (Unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2014 and 2013 (Unaudited), (iv) Condensed Consolidated Statements of Changes in Equity for the six months ended June 30, 2014 and 2013 (Unaudited), (v) Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2014 and 2013 (Unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (Unaudited).

 

*

Filed herewith.

 

 

 

57


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

KRATON PERFORMANCE POLYMERS, INC.

Date:

July 31, 2014

/s/ Kevin M. Fogarty

 

 

Kevin M. Fogarty

 

 

President and Chief Executive Officer

 

 

 

Date:

July 31, 2014

/s/ Stephen E. Tremblay

 

 

Stephen E. Tremblay

 

 

Vice President and Chief Financial Officer

 

58